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Abstract 
Neglected helminths affect nearly a billion people in developing countries. This study aimed to 
investigate: 1) impact of preventive chemotherapy (PCT) on helminth infections; 2) polyparasitism 
and associated health indicators; 3) associations of helminth infections and atopy. 
The study was undertaken in rural and urban districts of Tanzania. The rural districts were Kwimba 
and Sengerema (Mwanza region and the urban districts were Kinondoni and Temeke (Dar es Salaam 
region). A total of 2,708 and 2,431 study participants were enrolled in the surveys conducted from 
June to July in 2013 and June to October in 2014 respectively. In 2013, one round of treatment with 
ivermectin and albendazole was administered to the whole population 5 years and above and 
praziquantel administered to School aged children (SAC) in Dar es Salaam districts. In Mwanza 
districts, albendazole and praziquantel were administered to SAC. Study participants included at 
total of school children 1,391 in the year 2013 and 1,084 in the year 2014 who were aged 5-17 years. 
Urine, stool samples and anthropometric measures were taken from 5-17 years old while blood 
samples were taken from all participants. Laboratory tests included: stool microscopy for soil 
transmitted helminths (STH) and Schistosoma mansoni; urine microscopy for Schistosoma 
haematobium; and blood tests for lymphatic filariasis, malaria and full blood count. Children aged 5-
17 years underwent skin prick test with dust mite and cockroach allergens. 
In 2013, the overall prevalence of lymphatic filariasis (LF) was 45/2,681 (1.7%) S. haematobium was 
73/749 (9.8%) S. mansoni 11/752 (1.5%) and hookworm infection was 21/752 (2.8%).The Geometric 
Mean Intensity (GMI) for S. haematobium was 10.4 egg/10ml among infected participants while the 
intensity of S. mansoni and hookworm were 410.8 and 318 eggs per gram of stool (EPG) among 
infected participants respectively. 
In 2014, prevalence of S. haematobium was 22/804 (2.7%), 11/752 (1.4%) for S. mansoni, 17/804 
(2.1%) for hookworm and 37/2,321 (1.6%) for LF. The GMI for S. haematobium was 7.8 egg/10ml of 
urine among infected individuals while the GMI for S. mansoni and Hookworm were 40.4 and 70.7 
EPG respectively.  
In both years of surveys, no cases infected with Trichuris trichiura or Ascaris lumbricoides were 
found. Moreover, none of the cases infected with Schistosoma species were noted in urban areas. 
LF was found more in urban and rural areas. 
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A crude reduction in prevalence of S. haematobium by 74% (p<0.001) in 2014 compared to 2013 and 
also 67% for S.mansoni infection (p=0.052). There was no significant change in prevalence of 
hookworm and LF infections. Furthermore, a significant reduction of GMI of S. mansoni and 
hookworm was observed.   
Univariate associations were observed between stunting and S.mansoni (p=0.06) and hookworm 
(p=0.002) while for anaemia was between S.haematobium (p=0.01), hookworm (0.002) and malaria 
(p<0.001). Multivariate associations of infection and health indicators included: hookworm with 
stunting (p=0.03) anaemia with and anaemia with malaria (p<0.001).  
After one round of PCT about 38% reduction in overall stunting was noted but was not significant in 
participants infected with helminth infections. Anaemia decreased in urban areas by 47% after one 
round of MDA while it generally increased mostly in rural areas despite an effective treatment of 
helminth infections. This increase is explained by an increased prevalence of malaria which was also 
noted.  
Univariate association indicated that participants from rural areas were more often positive for the 
skin prick test using Dermatophagoides farinae (p=0.0001) and D. pteronyssinus (p=0.004) allergens 
and for cockroach was less by 60% (p=0.0004). Hookworm infection was associated with reaction to 
D. pteronyssinus (p=0.01) and S.mansoni infection was associated with D.farinae (p=0.06). In 
multivariate analysis, only hookworm and D. pteronyssinus dust mite were significantly associated 
(p=0.005).The reasons for these findings need to be addressed in further studies. However, one 
explanation would be cross reactivity of allergens with helminths antigens.  
A reduction in prevalence of S. haematobium and intensity of S. mansoni, and hookworm was 
observed following one round of MDA. Moreover, a positive association between helminth 
infections prevalence and its impact indicators was observed. Therefore, multiple MDA and 
longitudinal monitoring of infection and health indicators is recommended.  
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1. INTRODUCTION 
1.1. Overview and organization of the thesis 
This study was conducted with the overall goal to determine the impact of Preventive Chemotherapy 
(PCT) also known as Mass Drug Administration (MDA) on helminth infections in rural and urban 
endemic districts of Tanzania. The work was done in year 2013 and 2014 in selected 4 districts 2 in 
Dar es Salaam regions (urban) and 2 in Mwanza (rural) districts. This thesis work is designed to 
describe the global and regional burden of helminths specifically together with its correlation with 
health indicators such as anaemia and nutritional status.  A description of the control and elimination 
efforts at global and regional level is also included. The situation of helminth infections burden and 
control efforts in Tanzania is also described in detail. 
The rationale of the study is stipulated to describe the gap in understanding the effect of MDA on 
helminth infections and its associated heath indictors in endemic communities. Description of the 
Study design, approach used to collect data and analysis is provided in the methods and procedures 
sections. Included in the results section is the study population, prevalence of helminth infections, 
intensity of helminth infections and association between health indicators and helminth infections. 
Furthermore the relationship between helminths and allergies specifically against house dust mites 
(Dermatophagoides farinae, D. pteronyssinus) and cockroach (Blatella germanica) was also described. 
The discussion section explains in detail the study findings and its comparison to what other 
researchers have found in same aspects in various settings of the world. 
1.2. Neglected tropical diseases and helminth infections  
Neglected Tropical Diseases (NTDs) are a group of chronic diseases that are endemic in tropical and 
subtropical countries. NTDs persist in the poorest and the most marginalized communities in rural 
and urban places with unsafe water, poor sanitation, and limited access to basic health care [1, 2]. 
Neglected Tropical Diseases can be fatal, but primarily cause acute clinical symptoms and chronic 
lifelong disabilities, leading to disfigurement, impaired child growth, poor pregnancy outcomes and 
impaired economic development [3]. 
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The World Health Organization (WHO) estimates that at least one (1) billion people are affected from 
one or more of the NTDs. A further two(2) billion are at risk of infection in tropical and subtropical 
countries [4]. NTDs are associated with poverty and various disadvantages. It is estimated that 1.2 
billion of the world’s poorest (2.7 billion living on less than US$2 per day) are affected by NTDs [5]. 
 
NTDs are caused by helminths, bacteria, viruses and protozoa and almost exclusively affect 
impoverished people living in rural areas or urban slums in low income countries[6]. In Sub-Saharan 
Africa, almost 85% of the burden of NTDs is due to helminths [7, 8].  
Recognizing the public health and socio-economic consequences associated with NTDs; particularly 
those caused by helminths namely- Lymphatic Filariasis (LF) Onchocerciasis and Soil Transmitted 
Helminthiases (STH); the WHO and other partners rose to the challenge and spearheaded efforts for 
the control of NTDs. In December 2003, the WHO, the Germany Technical Cooperation (GTZ) the 
German Ministry of Development and Technical Cooperation (KFW) the German Ministry for Health 
and Social Security and the Special Programme for Research and Training in Tropical Diseases (TDR) 
hosted the first WHO/GTZ meeting involving experts from various sectors. The meeting set the 
agenda for intensified control of NTDs as a group (due to diseases overlap) rather than a disease 
specific approach. Another meeting was held in April 2005 in Berlin after which an NTD department 
was formed at the WHO. A partners meeting on NTDs was held in April 2007 bringing together 
partners from endemic countries, pharmaceutical and donor countries to gain support for NTDs. 
From this time an integrated diseases centered approach to health needs for quick wins and meeting 
the MDGs targets was realized. Moreover, multiple approach including strengthening vector control, 
broader rapid coverage of interventions, improved surveillance and care for affected populations 
has been attained. WHO headquarters through its NTD department works in a cascade manner, 
where by its regional offices are located in all continents. Regional offices work with WHO-country 
offices. In Sub-Saharan Africa the office responsible for NTDs is known as WHO AFRO. At WHO –
AFRO, NTDs are under the communicable Diseases cluster. Currently, there is a special project for 
the elimination of NTDs (ESPEN) which coordinates the control and elimination of the 5 PCT diseases 
namely; LF, Trachoma, STH, Onchocerciasis and Schistosomiasis. 
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WHO headquarters has been working through its regional and country offices in collaboration with 
multiple stakeholders, including ministries of health in endemic countries .Endemic countries have 
adopted various WHA diseases specific resolutions and have stepped up efforts to eliminate these 
diseases from endemic districts/areas. Majority of endemic countries have initiated the control and 
elimination programmes, whereby donated medicines are distributed through MDA. The free 
donations of Medicines is done by Pharmaceutical companies such as Pfizer, GlaxoSmithKline (GSK) 
and Merck.  
These efforts on NTD elimination and control were reinforced in 2012 when the London Declaration 
on NTDs came into effect/or was initiated. Through the declaration  donors and endemic country 
governments, private sector leaders, pharmaceutical companies and multilateral organizations 
made commitments and announcements for a close partnership to control or eliminate NTDs by 
2020, in line with World Health Organization (WHO) targets and the 2020 Roadmap on NTDs [9]. In 
2013 a comprehensive resolutions WHA66.12 was adopted which calls for member stated to 
implement, expand and monitor NTD control and elimination activities[10]. 
 
1.3. Background 
1.3.1. Neglected Helminth infections: the global situation and Preventive Chemotherapy (PCT)  
Among NTDs, helminths are estimated to be spread worldwide, especially in the tropics and sub-
tropics. Africa accounts for about 85% of disease burden due to helminths [7]. Among the NTDs; 
there are 4 helminthic diseases that are targeted for preventive chemotherapy through MDA: soil-
transmitted helminthiases, schistosomiasis, lymphatic filariasis (LF) and onchocerciasis [6, 8]. 
Preventive chemotherapy is the strategy recommended by WHO to alleviate the suffering, reduce 
morbidity and interrupt transmission of helminth infection using quality medicines. The intervention 
is administered at population level at regular intervals for a defined period of time. PCT, sometime 
referred to as Mass Drug Administration (MDA) involves treatment of entire endemic population 
regardless of individuals’ infection status. PCT has shown to have significant impact on helminth 
health indicators such as its prevalence and intensity,  relationship with nutritional status (stunting, 
underweight and wasting) anaemia as well as lesions of urinary tract and liver [11, 12]. Several 
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studies have indicated a reduction of disease prevalence and intensity following MDA with 
anthelminthic medicines. For instance, Zhang et al., found a significant reduction of prevalence and 
intensity of infection with helminth in high risk population in Uganda after only 2 years of treatment 
[13]. In Burkina Faso, it was revealed, that even a single round of mass chemotherapy could have a 
substantial impact on S. haematobium infection and its associated morbidity in children [14]. 
Anaemia is acknowledged as one of the most important public health concerns world-wide with 
estimates from WHO showing two billion people to be affected [15]. Multiple factors are reported 
to be the causes for anaemia. However, anaemia due to iron deficiency is largely caused by parasitic 
infections including helminths. Helminths such as STH cause anaemia mostly in children and 
pregnant women. Studies in Uganda and Tanzania have revealed that anaemia associated with 
schistosomiasis and geohelminths like hookworm can be significantly reversed with chemotherapy 
[16, 17]. Furthermore studies indicate that coexistence of multiple helminth infection have an effect 
on anemia despite the low intensity profile [18]. 
1.3.2. Helminths and eosinophilia  
The eosinophils are white blood cells responsible for inflammatory processes including allergic 
disorders. Eosinophilia is a condition in which blood cells known as eosinophils count is greater than 
7% of the circulating white blood cells (WBC) [19]. It is known to be caused by several factors 
including atopy, parasitic infections like helminthes and neoplastic disorders. Correlation of helminth 
infections and eosinophilia has been studied in various places. Most results indicate that eosinophilia 
can serve as one of the clues for helminths infections if other causes are excluded [20-22]. Leder et 
al. found that multiple helminth infection is associated with eosinophilia [23]. Furthermore, a study 
conducted in southern Spain on immigrants indicated that eosinophilia was resolved in 93.9% 
individuals after empirical treatment with albendazole, ivermectin and praziquantel [24].  
1.3.3. Helminths and atopic diseases 
Atopy, sometimes used interchangeably with allergy, refers to an inherited tendency to produce IgE 
antibodies in response to small amounts of common environmental proteins such as pollens, house 
dust mites and food allergens. Most commonly atopy affects the nose, eyes, skin and lungs. Atopic 
disorders include extrinsic atopic dermatitis, immune-mediated urticaria, immune-mediated 
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angioedema, some allergic lung disorders, like asthmatic diseases (allergic Asthma) and allergic 
venomous stings. 
Allergic diseases are becoming an important health threat both to individuals and society because 
they have reached epidemic proportions in developed and developing countries as well [25]. Atopic 
diseases are more common among adolescents beginning from childhood. They manifest firstly, as 
atopic dermatitis which is considered an initial stage in the atopic march. It is a very common 
inflammatory skin condition which poses a considerable cost on the health care system. It affects 
15%-20% of children and 1-3% of adults’ worldwide [26]. 
Relationship between helminths and allergic diseases has been reported in several studies. Decades 
ago an increase in allergic diseases and asthma was noted in industrialized countries Efforts were 
undertaken to control infectious diseases and the so called “hygiene-hypothesis” was formulated by 
D. Strachan [27, 28]. A negative association was described between different helminth infections 
[29, 30]. Although helminthes can modulate the host inflammatory response directed against the 
parasite, a causal association between helminthes and atopic diseases remain uncertain. Different 
helminth parasites may have different effects on allergy depending on the time of exposure[31]. To 
date, reports on the relationship between the infections with helminthiases and allergies have been 
contradictory [32-34]. There are findings that have indicated helminthes infection have negative 
association with allergies [35, 36] while other have shown a positive association [37]. Helminth 
eradication programmes are challenged with the question of whether their efforts may lead to an 
increase in atopic diseases. However, a randomized study done in Ecuador indicated that there were 
no increased atopic symptoms between the group that received two monthly albendazole and the 
one that did not receive albendazole [38]. Although several studies have been done in the area of 
multiple infections, interrelationships between helminth infections and atopic diseases, the ongoing 
discussion and inconclusive results require more studies. 
1.3.4.  Helminth existence in urban and rural areas 
The existence of helminth infections has been studied extensively in both rural and urban areas. The 
difference in prevalence depends on cultural, occupational, social and environmental factors. A 
study by Curtale et al., in Egypt indicated that urbanization has deteriorated the living conditions 
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and sanitation thus attracting helminth infections [39]. A study in Pemba Island indicated no 
difference in intestinal infections among rural and urban children [40]. 
1.3.5. Helminth and Nutrition 
Helminth infections have effect on nutritional status due to the fact they feed on blood and other 
gut contents of host individuals. This brings about loss of appetite as well as impaired growth and 
development of host individuals Nutrition status indicators includes stunting, thinness and 
underweight.  Numerous studies indicate the co-prevalence of nutritional disorders and STH 
infections in developing countries. Studies conducted in Ghana, Tanzania, Vietnam, India and 
Indonesia showed that the prevalence of stunting ranged between 48% and 56% while that of 
underweight ranged between 34% and 62.% [41].Moreover, the World Development Report (2011) 
indicated an estimated 100 million people  have experienced stunting or wasting as a result of 
geohelminths infections[42].  
On the other hand, interventions to eliminate helminth infections have as one of their aims been to 
reduce problems associated with nutrition status (WHO, 2001). In Uganda for instance, studies 
indicated weight gain of 10% above the expected among school children in areas where periodic 
provision of anti-helminthic treatment was conducted [43]. 
1.4. Epidemiology of Neglected Helminth infections 
1.4.1. Schistosomiasis 
Schistosomiasis is one of the most common helminth infections, endemic in 76 countries with 652 
million people at risk of infection [44]. It is estimated that 203 million people are infected with 
schistosomiasis worldwide, with more than 90% of the disease burden in sub-Saharan Africa [45]. 
Schistosomiasis is caused by infection with trematodes S. mansoni, S. mekongi, S. japonicum and S. 
intercalatum. Urinary Schistosomiasis is caused by infection with S. haematobium. The major 
contributory factors to such high levels of infection are limited access to safe water and lack of or 
poor environmental sanitation. Individuals are therefore continually exposed to the parasites and 
re-infection levels are high (in most areas). The consequences of these diseases include blood in 
urine, diarrhoea, hepatomegaly (35%) and/or splenomegaly (80%) [46]. Chronic intestinal 
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schistosomiasis results in severe organ pathology such as hepatosplenomegaly, periportal liver 
fibrosis and portal hypertension which progress from abdominal pain and bloody diarrhea. 
Urogenital schistosomiasis leads to hematuria, dysuria, hydronephrosis and calcification of the 
bladder and seem to increase the risk of those with HIV infection [47]. These morbidities contribute 
to, amongst others, anaemia, growth stunting and cognitive impairment in infected individuals [17, 
48]. Globally, schistosomiasis alone is estimated to cause about 300,000 deaths per year, although 
this is thought to be a significant underestimate because the schistosomiasis-related deaths are 
rarely stated as such in hospital records and death certificates [48]. 
Control of Schistosomiasis aims to reduce transmission of parasites and reduce the level of infection 
in individuals in order to minimize the pathological effects. The predominant intervention for control 
is annual treatment with one dose of praziquantel (PZQ, at 40mg/kg) where number of tablets 
received is determined by a dose pole which: devised as proxy for weight to be used in MDA settings 
[51]. Annual treatment should be supported by improved access to safe water, adequate sanitation 
and where feasible, snail control [45, 49]. Mass chemotherapy campaigns with PZQ are targeted at 
school-age children (SAC) as they harbor the heaviest worm burden in a population. The target 
should be to reach at least 75% therapeutic coverage of SAC at risk of infection [53]. WHO also 
recommends that those at high-risk, for example, fishermen and women who frequently visit 
contaminated water sources, should also be targeted for mass treatment (WHO, 2001). 
1.4.2. Soil-transmitted helminths 
The four most prevalent soil transmitted helminths (STH) species worldwide are: Ascaris 
lumbricoides (roundworm) Trichuris trichiura (whipworm) Ancylostoma duodenale and Necator 
americanus (hookworms). In case of A. lumbricoides and T. trichura eggs are deposited in the faeces 
and then into the environment. These eggs can be ingested through contaminated food or through 
dirty hands. For hookworm the larvae penetrates the skin of human directly from the infested soil. 
STH infections morbidity status varies and is dependent on intensity [50]. Some of the effects of STH 
include impaired growth and development of children. Studies indicate that the diseases affect one 
third of the global population with over 300 million people having chronic manifestations [51, 52].  
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Diagnosis of Hookworm and Trichuris infections is commonly through the same method used for S. 
mansoni infection. This is through counting the number of eggs per gram of faeces using direct smear 
and the Kato Katz technique. The major aim of control activities is to reduce morbidity control 
through treatment of at-risk populations to reduce the intensity of infection and protect infected 
individuals from further morbidity (WHO, 2010). Encouraging healthy behavior such as, hand 
washing and using latrines as well as provision of safe water are other important control measures 
for STH control [68]. Treatment is either with a single tablet of albendazole (ALB, 400mg) or 
mebendazole (MEB, 500mg). ALB can be safely co-administered with ivermectin (IVM) for the 
treatment of lymphatic filariasis and ALB or MEB can be safely co-administered with PZQ for the 
treatment of schistosomiasis. Mass treatment is delivered once or twice a year depending on the 
underlying endemicity with therapeutic coverage of 75% and above in SAC (WHO 2006).  
 
1.4.3. Lymphatic filariasis 
Lymphatic filariasis (LF) is caused by long thin filarial worms (Wuchereria bancrofti, Brugia malayi 
and B. timori) that live in lymph vessels in the human body and are transmitted by mosquitoes of 
Anopheles, Culex, Aedes and Mansonia genera [53]. Worldwide, the infection with W. bancrofti is 
the most wide spread of the human lymphatic filarial parasites and it is the only one transmitted in 
Africa [53, 54]. Transmission between humans and mosquitoes takes place when mosquitoes take a 
blood meal. Microfilariae (mf) are produced by the female adult worms in the lymphatics. They 
migrate to the blood system where they circulate and may be ingested by mosquito vectors. In the 
vectors they develop through various larval stages to an infective stage-L3. The infective stage larvae 
infect humans and migrate to the lymphatics where they develop into adult male and female worms. 
Adult worms have a life span of up to 20 years (but have been estimated to have an average life span 
of 5-12 years) while the mf may survive for approximately one year. 
Several clinical features characterize LF. Some individuals may exhibit no obvious clinical 
manifestations though they are infected. Clinical manifestations begin with acute attacks 
characterized by fever, general body malaise and enlarged painful lymph nodes. This acute attacks 
are known to occur at irregular intervals [53, 55]. Chronic manifestations of LF include hydrocele 
(which affects men) and lymphedema or elephantiasis (which affects mainly the limbs of both males 
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and females). Women have also been known to have filarial infections of the breast and genitalia, 
although these are very rare. Chyluria, which presents a secretion of a milky like urine, is also 
acknowledged as one of clinical complications due to LF. About 5.5% of people affected by LF are 
known to have this complication in  Niger Delta [56].  
Lymphatic Filariasis is a disease of major public health importance which affects an estimated 120 
million people worldwide; of which 44% are in sub-Saharan Africa [7, 57]. Although LF is not 
associated with any significant mortality, its debilitating chronic complications (hydrocele, 
lymphedema and elephantiasis)  causes  significant suffering and social stigma to the affected 
individuals and impedes economic performance of endemic communities [58]. Lymphatic filariasis is 
found mainly in remote rural areas and in some urban or peri-urban areas, where due to unplanned 
expansion of towns and cities, significant proportions of population have been forced to live in slums 
where mosquito breeding sites are a common feature [59]. This coupled with the heavy toll exerted 
by the chronic nature of the disease perpetuates the predicament at the individual level and endemic 
communities at large [60]. Acute attacks and microfilaremia is higher in early age groups with an 
increased risk in males; while elephantiasis and hydroceles manifestations are more common in 
older population [61-63].  
Current methods for LF diagnosis rely on detection of circulating filarial antigens (CFA) in the blood, 
tested against the gold standard for diagnosis of detecting mf in the blood. The CFA are metabolic 
products released by adult worms. Detection of CFA indicates presence of adult worms. Given the 
fact that infected individuals have adult worms but no mf, the prevalence of CFA is usually much 
higher than the prevalence of microfilaraemia [64]. 
Efforts to effectively control LF have evolved through several decades. Developments in new 
diagnostic tools and treatment strategies have made the possibility of controlling LF appear more 
likely [54]. In 2000, the Global Programme to Eliminate Lymphatic Filariasis (GPELF) was launched 
following  recommendation by the Task force for Disease Eradication World Health Assembly and 
the Resolution of 1997 WHA 50.29. The aim of the Programme is to eliminate LF as a disease of 
public health and socio-economic concern by the year 2020. The first component of GPELF is to 
interrupt transmission with annual single dose of albendazole in combination with either DEC or 
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ivermectin. This should be offered to all eligible populations in endemic communities in order to 
suppress microfilaraemia by killing circulating microfilariae produced by the adult worms and 
thereby preventing transmission. The drug combinations have other ancillary benefits in providing 
treatment of intestinal helminth infections [65]. For effective elimination of LF it is crucial that a high 
proportion of eligible persons in the community receive the single annual doses for a period of at 
least 5 to 6 years. Repeated rounds of treatment with high drug coverage are therefore required to 
reduce the infection and disease burden related to LF. The recommended period of 5 to 6 years 
corresponds to the reproductive lifespan of the adult parasitic worms [54]. The second pillar of the 
program refers to care for those already affected by manifestation of the disease. This is a crucial 
component in relieving individual suffering; which to some extent; increase drug uptake during 
MDAs [66]. 
1.4.4.  Onchocerciasis 
Human onchocerciasis (river blindness) is a helminths disease of humans caused by Onchocerca 
volvulus. It is characterized by skin and eye lesions. The parasite is transmitted through the bite of 
infected female black flies (Simulium damnosum s. l. and S. neavei s. s.) which breed in fast flowing 
rivers and streams. The disease manifests mainly as onchocercal skin disease characterized by severe 
itching and skin lesions. Itching can be so severe that it disturbs sleep, concentration and work [67]. 
The disease is endemic in 37 countries in sub-Saharan Africa, South America and 2 Arabian countries 
[68]. 
Approximately 42 million individuals are estimated to be infected with O. volvulus of which there are 
13.1 million cases of severe itching and 385,000 cases of blindness as a result of the disease [69].  
 
Early attempts to address the disease in Africa focused on vector control by spraying river banks. 
The Onchocerciasis Control Programme in West Africa (OCP) which was based on vector control was 
successful in eliminating the diseases from ten endemic countries in West Africa. The intervention 
was used in some foci in Tanzania, Uganda and Equatorial Guinea and was reported to be effective. 
Implementation costs were found to be the major barrier. Following on from the success of OCP the 
African Programme for Onchocerciasis Control (APOC) was established in year 1995 with the main 
objective of eliminating onchocerciasis as a public health problem in non-OCP countries. The 
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Programme was based on annual community-directed treatment with ivermectin (CDTI) as the main 
intervention in most areas except in a few foci where semi-annual treatment is implemented. In the 
America, semi-annual ivermectin treatment with a minimum coverage of 85% is the main 
intervention; but recently, quarterly treatment has been implemented in some foci. Recent findings 
have shown the possibility of elimination of onchocerciasis in most countries and a Guideline for 
Stopping mass drug administration and verifying elimination of human onchocerciasis has been 
adopted [69]. 
1.5. Neglected Helminth Infections in Tanzania 
Tanzania is endemic for a number of neglected tropical diseases including onchocerciasis, lymphatic 
filariasis (LF) schistosomiasis, trachoma, soil transmitted helminthiases, Human African 
Trypanosomiasis, rabies, plague, echinococcosis, cysticercosis and brucellosis. Four of the diseases 
(onchocerciasis, lymphatic filariasis, schistosomiasis and intestinal helminthiases) are helminths and 
are under preventive chemotherapy control for which the mass drug administration has been 
adopted. Previously, these diseases were controlled through individual vertical programmes (MoH, 
2010). The helminth infections that were focused on included LF, STH and schistosomiasis with 
limited (phased approach) MDAs implementation. For onchocerciasis treatment had been on-going 
in focal areas for several years before the surveys. MDA for the studied diseases i.e LF, STH and 
schistosomiasis were initiated in the selected districts. 
In Tanzania Schistosomiasis is endemic country wide with very high prevalence of over 50% in over 
half the country, particularly in the six regions around Lake Victoria and in the four coastal regions 
including Dar es Salaam, Zanzibar and Pemba. Control has been targeting School Aged Children (SAC) 
with annual or biennial treatment with Praziquantel (40mg/kg) for high-moderate and low 
prevalence districts respectively. 
STH are endemic in 80% of the country with a predicted prevalence of between 20-49% in most of 
the country reaching over 50% in some parts. School age children are targeted for control efforts 
due to the high prevalence of STHs among that group. The main intestinal parasites include 
hookworm, whipworm (Trichuris trichiura) and Ascaris lumbricoides.  
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Lymphatic filariasis is endemic in the whole of mainland Tanzania. Rapid mapping for lymphatic 
filariasis (LF) completed in Tanzania in 2004 indicated that all districts in the country are endemic. 
The circulating filarial antigen (CFA) prevalence ranged between 1%-69% with high prevalence along 
the coastal areas and decreases towards the inland [70]. Mass control of LF began formerly in year 
2000 with the launching of the Tanzania Lymphatic Filariasis Elimination Programme (NLFEP). The 
elimination strategy is based on once yearly administration of two single dose drugs namely; 
ivermectin (150 µg/kg and albendazole (400mg); administered together.  NTD programme report 
indicate that the number of districts requiring MDA has come down from 101 districts in year 2014 
to 47 districts in year 2017 based on transmission assessment surveys (TASs) results. In case of 
patient care, activities are designed to establish community home-based self-care for people with 
lymphedema and to provide access to surgery for men with hydrocele. 
1.5.1. Helminth Infections and co-endemicity in Tanzania  
Helminth infections and their comorbidity have been studied in a number of settings with most 
studies focusing on STH and schistosomiasis [71, 72]. Studies in Tanzania indicated that individuals 
with multiple species infections are likely to be at the highest risk of geohelminths-related morbidity, 
not only because of the number of infections they harbor, but also because they generally carry 
heavier infections of each species [73-76]. Prevalence of single and multiple species helminth 
infection in school children revealed that S. haematobium, hookworm and S. mansoni were the most 
common helminths affecting school children. It was also found out that hookworm and S. mansoni 
occurred more frequently in multiple infections with other infection than as single species infection 
[76]. The relationship between HIV, lymphatic filariasis, malaria (Plasmodium falciparum) and 
intestinal helminths (Ascaris lumbricoides, Trichuris trichiura and hookworm) showed that 
hookworm infection was positively associated with W. bancrofti (CFA) infection and malaria but, 
surprisingly, a negative association with HIV infection. This situation was associated with a significant 
reduction in haemoglobin concentration [77]. 
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1.5.2. Integration of helminth Control and elimination in Tanzania  
The Neglected Tropical Diseases Control Programme was established in 2009 in-line with the WHO 
recommendation for NTD control in the African region. It works with local government authorities 
at regional and district level to provide Preventive Chemotherapy (PCT) services; among other things; 
to the affected communities. The neglected Tropical diseases targeted by PCT in Tanzania include; 
Lymphatic Filariasis, Schistosomiasis (SCH) and soil transmitted Helminthiasis, Onchocerciasis and 
Trachoma. Tanzania is one of the first WHO African regional countries to integrate the coordination 
and implementation of the 5 PCT-NTDs diseases control/elimination activities, including MDA, health 
education and morbidity management.  
Results of mapping and several surveys of these helminth infections have shown that prevalence 
and intensities of infection differ from one place to another despite the overlap. Recently, Tanzania 
has moved towards integrated approach of the NTDs whereby, most/all NTDs activities are 
coordinated under one umbrella (the NTD program). This integrated approach is aimed at reducing 
duplication, maximizing the effect of control/elimination of the NTDs and ensuring prudent use of 
the available meagre resources. ,  
Prior to 2009 all control and elimination efforts of the helminth diseases were conducted by separate 
programmes namely; Schistosomiasis and soil transmitted helminth control programme, National 
Onchocerciasis Control programme and the National LF elimination Programme. In year 2009 
implementation of the integrated MDA approach was established. It started with the MDA in 36 
districts endemic for more than 2 NTDs including the helminth infections. Upscaling to more districts 
was carried out in phased approach. In 2012 more districts were added to reach 92 and by year 2015 
the country achieved full (100%) geographical coverage. For onchocerciasis full coverage was 
attained by 2009, for LF in 2014 and for STH and SCH in 2015/16.  
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2. RATIONALE AND OBJECTIVES 
2.1. Rationale 
Control of schistosomiasis, soil-transmitted helminthiasis (infections with Ascaris lumbricoides, 
Trichuris trichiura and hookworm) and elimination of lymphatic filariasis is largely dependent on 
preventive chemotherapy (PCT). For all of these helminth diseases, donated or affordable drugs are 
available for effective prevention and control. These drugs, when used in preventive chemotherapy, 
have the power to interrupt transmission of burden caused by these ancient scourges of humanity. 
Control/elimination of these diseases coordinated and implemented through the Ministry of Health 
and education to reduce the disease burden to a level that they will no longer be of public health 
problem in the respective communities. Implementation of the programs is organized at district level 
and is included in the Comprehensive Councils health plans (CCHPs) which are prepared on annual 
basis.  
Through the national programme, control of NTDs in an integrated approach was adopted in 2009 
whereby, the MDA of these diseases using a combination of drugs that have so far been used was 
initiated. However, despite the already growing recognition of the role of multiple infections, and 
the fact that integrated control is taking place in some countries including Tanzania, it was unclear 
how the combined mass treatments would affect the population dynamics of the multiple species 
and overall helminths infection status in endemic communities. In essence, the fact that very few 
studies have sought to investigate multiple infection patterns and population dynamics; the dearth 
of information on how MDA alters the effects of polyparasitism; and the paucity of knowledge 
regarding the significance of polyparasite infection in parasite induced morbidity, contributed 
greatly to the lack of clarity pointed above.  
Therefore, this study was carried out in 2 surveys one in 2013 and another one in 2014. Information 
collected included STH, schistosomiasis and LF infections with health indicators such as anaemia 
nutritional status and allergy surrogate marker prior to MDA and after round of MDA. It is envisaged 
that preventive chemotherapy for helminth have a significant impact on these indicators. 
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2.2. Research Question(s) and/ or Hypotheses 
 Does preventive chemotherapy have impact on the overall helminth infections and its 
associated health indicators in selected urban and rural areas? 
 Is there any effect on polyparasite infection and its associated health indicators after 
rounds of PCT/MDA? 
 Is there a relationship between helminth infections and atopic diseases? 
 
2.3. Study Objectives  
The main purpose of this study was to determine the health impact of integrated preventive 
chemotherapy on selected NTDs in urban and rural endemic districts of Tanzania. Specifically, the 
study aimed: 
 To determine the impact of preventive chemotherapy on helminth prevalence, 
intensities and associated health indicators in rural and urban areas. 
 To determine the prevalence of polyparasitism helminth infections and its associated 
health indicators before and after MDA and morbidity in rural and urban areas. 
 To determine the association of helminth infections and atopic disease in rural and urban 
areas. 
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3. METHODS  
3.1. Study Design  
Follow up surveys were conducted in 2013 and 2014 to determine the health impact of integrated 
preventive chemotherapy on LF, SCH and STH infections through prevalence and intensity. The 
districts were purposively selected based on the findings from the estimates of the Mapping surveys 
conducted by the Ministry of Health through its programmes as well as limited MDA.  
In Kwimba, Sengerema, Temeke and Kinondoni districts, baseline data was collected in year 2013 
and included participants 5 years and above. Moreover, in all the surveyed districts the baseline data 
was collected prior district-wide MDA.  
Mass drug administration was conducted at least once in all surveyed districts soon after baseline 
data collection. It included administration of praziquantel and albendazole to all school aged children 
for SCH and STH control. Ivermectin and albendazole tablets were administered to all people above 
5 years of age for LF in all surveyed districts except Kwimba and Sengerema, (figure 3.1). Moreover 
in 2014 survey in Kwimba, Sengerema, Temeke and Kinondoni, the effect of helminth treatment on 
atopic diseases was assessed. 
3.2. Study population and Area 
Tanzania is situated in the East of Africa located between 6.36900 S and 34. 888o E has an areas size 
of 947,303 Square Kilometer .The country has a population of 51.8 million with 26 regions and over 
160 districts [78]). In year 2013 baseline was collected from 4 districts in 2 the regions of Dar es 
Salaam and Mwanza namely Kwimba, Sengerema, Temeke and Kinondoni .These districts had not 
initiated district-wide MDA by 2013. Follow up was conducted in the same districts.  
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Figure 3.1: Map of study sites 
 
3.3. Study Sites 
3.3.1. Kwimba District 
Kwimba district is one of the eight districts in Mwanza region near Lake Victoria. The district lies 
between latitude 2o 45‟ to 3o 53‟ south of the equator and longitude 33o to 33o.30‟ east of 
Greenwich. The district occupies an area of 3,903 km
2 of land. The district has no water surface area, 
since it has neither lakes nor permanent rivers. Kwimba district lies between 1000m to 1200m above 
sea level. It has a moderate warm climate, with temperatures varying between 25o and 33o 
throughout the year. According to the Nation Population and Housing Census of 2012, the district 
had a population of 406,509 of which 198,096 were males and 208,413 were females with an annual 
average growth rate of 1.9%, population density of 104 people per square kilometer and a 
population size of 6.5. The district had a total of 62,540 households, of which 49,251 were in rural 
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areas and 13,289 were in urban areas. The district is composed of 5 divisions, 30 wards, 119 
registered villages and 802 sub-villages [79].The study was conducted in Ngudu and Sumve wards. 
Health services in the district comprise a network of 2 hospitals, 5 health centres and 51 dispensaries 
under the ownership of government and private institutions. The district’s social economic activities 
include agriculture, animal husbandry and petty businesses. The proportion of population with 
access to water supply is 58.7% only. The known endemic NTDs in the district are STH and SCH with 
the SCH average prevalence estimates from mapping surveys being 38.8. % and 1.4% for SCH and LF 
respectively [70, 80]. The Implementation of PCT started in year 2013 whereby, praziquantel and 
albendazole were administered to school aged children with coverage of 74 percent (74%). 
3.3.2. Sengerema District 
Sengerema district is also a district in Mwanza region. It lies between 2 o – 3o latitudes South of 
equator and 31o 45’ to 32o 45’ longitudes. Sengerema district has a bimodal rainfall pattern which 
consists of a short and long rains. The annual rainfall ranges from 800mm – 1200mm. The District 
mean temperature is between 21oC – 23oC with August being the hottest months. The District covers 
an area of 8,817 sq. km of which 3,335 sq. km is mainland, while 5,482 sq. km (62% of the total area) 
is covered by Lake Victoria where numerous islands are found. Administratively, Sengerema District 
is divided into five (5) divisions, 34 wards, and 126 registered villages also comprises of 765 hamlets 
of which 52 make the Sengerema township authority [81].The study was conducted in Busisi and 
Bupampwa wards. 
 Health service Provision is comprises of District Designated Hospital (Faith Based Organization) 9 
Health centers 56 Government dispensaries, 2 Private and 4 Faith based organization dispensaries. 
The major occupation is agriculture, livestock and fishing. East to the North Western part of the 
district there exist land slopes associated with a number of small hills and seasonal streams (rivers). 
Seasonal streams are also found in the eastern part of the district. Physical features of the district 
include also a number of manmade water bodies mainly dams of Sengerema, Buzilasoga, Sima, 
Nyamizeze, Nyakasungwa, Nyampande and Sotta. Sengerema District is characterized by an altitude 
which ranges between 900m – 1300m above sea level. By the year 2013, the District has been 
estimated to have total population of 711,632, of which 351,442 are males and 360,190 are females, 
with annual growth rate of 3.6%. This population is divided into five (5) divisions.  
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Sengerema had the LF prevalence of 5.3% and 23.8 % or Schistosomiasis at mapping around year 
2005[70, 80]. STH is also endemic in accordance to hospital records. The Implementation of PCT 
started in 2013 whereby praziquantel and albendazole were administered to school aged children 
with coverage of 64 percent (64%). 
3.3.3. Temeke Municipal Council 
Temeke Municipal Council is one of the five Municipalities within the Dar es Salaam City; the others 
are, Kigamboni, Ubungo, Ilala and Kinondoni. It is the largest in size compared to Ilala and Kinondoni 
Municipalities. It covers an area of 656km² with a coastal line of 70km length. Temeke Municipal 
Council lies in the Tropical coastal belt of Tanzania. It is therefore, influenced by three major climatic 
seasons, namely the long and short rains and the dry season which is characterized by high 
temperature. .High temperature prevails throughout the year ranging from 250c during the period 
of June to August up to 350c in the period of January to March. According to 2012 Census the current 
population is estimated to be 1,611,972. Administratively, Temeke Municipal Council is divided into 
3 divisions namely; Chan’gombe, Mbagala and Kigamboni. The divisions are further divided into 30 
wards; which are also divided into 180 hamlets. The study was conducted in Yombo vituka and 
Mjimwema wards. Health service delivery at the Municipal Council is based on preventive, 
promotive and curative care provided to the community at Dispensary, Health Centre and Municipal 
Hospitals. They are supervised by the Municipal Medical Officer of Health. The Council has 123 
Health facilities, 41 are owned by Government and 82 are privately owned. The public health 
facilities comprise 2 Hospitals (Temeke and Vijibweni), 1 Health Center (Kigamboni). NTDs endemic 
are LF, STH and SCH following previous prevalence surveys. Two rounds of MDA were conducted in 
2006 and 2007 but were stopped due to unavoidable factors. MDA was restarted in 2013 whereby 
albendazole and ivermectin were administered to the population aged 5 years and above while 
Praziquantel followed only to school aged children. Coverage rates were 53% and 42% for LF and 
SCH respectively.  
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3.3.4. Kinondoni Municipal Council 
Kinondoni Municipal is within the City of Dar es Salaam with an area of 531Km and population is 
about 1,775,049 (census 2012) with the increasing projection of 2,330,934 and population density is 
estimated at 2,051 person per square kilometer[82]. The Municipality is bordered by the Indian 
Ocean to the North East, Ilala Municipal to the South, Bagamoyo district to the North, Kibaha District 
to the west and Kisarawe district to the southwest. Administratively is dived into four (4) divisions 
namely: Magomeni, Kinondoni, Kibamba and Kawe. These divisions are then divided into 34 wards 
which in turn are sub divided into sub wards commonly known as 197 hamlets. The study was 
conducted in Bunju and Tandale wards. Kinondoni has well established healthcare system which 
provide both curative and prevent measure, it has a total number of 283 HFs both public and private 
in the following categories 19 hospitals, 13 health centers and 251 dispensaries. The social economic 
activities include working in (private and public sectors) petty trading, livestock keeping, fishing and 
agriculture. PCT diseases endemic include LF, SCH and STH and MDA was restarted in 2013 with 
coverage of 86% for ivermectin and albendazole while Praziquantel coverage was 49%. 
 
3.4. Sampling  
In the 2013 survey, study districts were purposively selected based on mapping survey estimates. 
Kinondoni and Temeke were chosen due to comparatively high prevalence rates for LF.  Sengerema 
and Kwimba were also selected due to high SCH prevalence. Two urban wards were purposively 
selected from Temeke and Kinondoni districts. Two rural wards from Kwimba and Sengerema 
districts were also selected through purposive sampling. The districts and wards were selected based 
on findings from mapping surveys. In each ward two schools and its surrounding streets/villages 
were randomly selected Village/school were selected). In each school 50 children from grade 3 and 
4 were enrolled .In the school surrounding areas, participants were selected from all hamlets and 
streets based on Population Proportionate Estimated sampling (PPES). A list of households was 
obtained from the hamlet office, and where this was not available, it was generated for survey 
purpose. The proportion of the population size of each street/hamlet for each ward was used to 
determine the required number of individuals to be surveyed per street/hamlet. An average 
household size of 5 people per household was used to determine the required number of households 
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to be surveyed in each hamlet. Sampling interval was determined by dividing total number of 
household in the ward by the number of households required from PPES. The starting point was 
selected using simple random number table. Then a sampling interval was applied to select 
subsequent households surveyed. In each household all members 5 years and above were enrolled 
for the survey.  
In the Impact surveys, conducted in 2014, sampling followed the same approach used in 2013 (figure 
3.2) in all study sites in the 4 districts of Kinondoni, Sengerema Kwimba and Temeke. 
 
Figure 3.2: Study Design  
3.5. Sample size calculations 
The sample size calculation was based on the determination of whether the prevalence of multiple 
infection at in year 2013 prior to the implementation of MDA in study sites is different from the 
prevalence of multiple infection after one round of MDA in year 2014 assuming that the matching 
ratio of samples size between the two group is 1:1. The calculations assumed the prevalence of 
multiple infection in year 2013 to be 35% in the study in each study site (ward) and wanted to see a 
reduction in prevalence in multiple infection of helminths in the year 2014, to 25% after one round 
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of MDA. A 95% confidence level was needed to detect a significant difference between the two 
prevalence of multiple infection. A power of 80% was set for detecting the effect size.  
Therefore the required sample size was calculated using following formula [83] 
n = (Z 1-α/2+Z 1-β) 2 * (p1 (1-p1) + p2 (1-p2)) / (p1-p2)2 
Where:  Z 1-α/2, for 95% confidence level α is 0.05 and the critical value is 1.96.  Z 1-β for a power of 
80%, β is 0.2 and the critical value is 0.84 and p1 (0.35) and p2 (0.25) are sample prevalence of the 
two groups. We estimated that a sample size of 326 per study site (ward).  
 
3.6. Data collection methods and procedures 
Data was collected on the following variables; Geospatial, biodata, anthropometric, and parasitology 
data as follows: 
3.6.1. Geospatial data  
Data was collected using GPS machines Garmin eTrex® where by a machine was set to record data 
at 5% precision .Variables on latitudes, Longitude and well as altitude was recorded. Point of 
references included types of water sources, forest, village center, school, health facilities and other 
prominent features. This was collected with aim of correlating the features with the helminth 
infections distribution. 
3.6.2. Biodata: 
This included sex, age, name of examinee, household head and place of residence (name of the 
village/street, district and region). Standard anthropometric included: weight, height and Mid 
Upper Arm Circumference (MUAC) and were measured using tape measure and weighing scale 
respectively. Height was measured in Centimeter (Cm) while weight was in kilograms (Kg) Mid 
Upper arm Circumference was measured in all SAC to determine their nutritional status. This was 
done to selected SAC in 2013 and 2014 data only. 
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3.6.3. Parasitological Examination:  
Special trained technicians collected and processed blood, urine and stool samples and the 
following procedures were conducted: 
3.6.3.1. Blood 
100 microliter was drawn into heparinized capillary tube and was placed on ICT card (BINAX NOW®) 
for detection of Circulating Filarial Antigen (CFA), specifically a capillary was placed on pink pad of 
the Card. Thereafter, the card was closed and labelled with ID of the individual. Time of blood 
application to the card was also recorded on top of the card. Results were read after 10 minutes in 
accordance to manufacturer’s instructions. 
Thick thick/thin smear (blood slides) was done for Malaria and other significant blood parasite was 
checked microscopically for authenticity of anaemia and or fever cause.  
Haematological investigation (Hb and eosinophil count respectively). Approximately 1 ml of blood 
was collected in the EDTA tubes and was analysed using haematology analyser MS59s. 
3.6.3.2. Stool samples  
Stool samples were collected within 24 hours of defecation and analysed in the field laboratory as 
well as at central laboratory. It was analysed visually for consistency where it’s formed, non-formed, 
loose, mucoid or bloody. 
Prevalence and intensity of geohelminths and S. mansoni ova was determined using Kato Katz 
technique [84]. The stool sample was processed immediately while still fresh. A small portion of 
stool from the sample container using a wooden spatula was taken from the container and 
smeared on a sieve and transferred to the slide templates. A piece of prepared cellophane with 
forceps was placed over stool each slide’s specimen. The slides were quantitatively examined 
under microscope then within one hour for hookworm ova. After at least 24 hours, the slides were 
quantitatively examined under the microscope for S. mansoni, Ascaris lumbricoides and Trichuris 
trichiura ova. 
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3.6.3.3. Urine sample 
The urine was collected in containers from the client and examined visually. Dipstick test was 
performed for testing blood in urine ; one half of the reagent strip was dipped into the urine sample 
for a few seconds and compare the color of the reagent strip to the colors on the label of the reagent 
strip container. Results were written on the laboratory form provided. 
Filtration technique was used for the detection of S haematobium ova: Urine was collected in a 
sterile container and the urine sample thoroughly mixed, 10 ml of urine was drawn using a syringe. 
Thereafter it was passed the through the filter and remove the syringe from the filter holder. The 
filter was placed on a glass slide and quantitatively examined under the microscope for S. 
haematobium ova. The number of eggs was recorded on the laboratory form. 
3.6.4. Skin Prick tests 
For allergic tests, skin prick tests against HAL Dermatophytes (D. farinae, D. pteronyssinus) and 
cockroach allergens (Blatella germanica) were done. Histamine was a positive control and normal 
saline was a negative control. The tests were performed for each allergen with positive and negative 
control. The skin was coded with marks of the allergens and controls (negative and positive) then 
allergens were dropped on each point using a specialised dropper. Thereafter tiny pricks were made 
in the middle of each drop using HAL lancets. According to manufactures instructions, results were 
read after 15 minutes whereby any induration was recorded and measured[85]  
 
Figure 3.3: Skin Prick Test   
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3.7. Data Management and Analysis 
Data from the field was collected using structured questionnaire forms during the baseline survey. 
All data collected from the individuals enrolled into the study was entered and edited using Epi data 
software version 3.2. During year 2014 (impact) survey the structured questionnaire was 
administered through mobile phones using the Open Data Kit (ODK) software. This data was then 
transferred to STATA version 12 software for subsequent analysis. Data was analyzed to provide a 
picture on the distribution (prevalence and intensity) of STH, schistosomiasis and LF before and after 
the implementation of MDA in the selected districts.  
 
3.7.1. Creating and defining variables for analysis 
Prior to the actual analysis of data several variables were formatted in suitable ways according to 
the standard definition recommended.  
Age reported by the participants was classified in 5 categories; 5-10 year, 11-17 years, 18-24 years, 
25-49 years,  50 years and above. This classification is based on target to start PCT in those aged 5 
years. This is because 5 to 17 is the school age in most of the study areas which is considered as the 
population at risk for at least 2 out of the 3 diseases of focus (schistosomiasis and STH) while age 18-
24 year represent youth who are considered the most vulnerable for mosquito bites due to outdoor 
exposure to mosquitoes and social economic activities (relevant for LF and malaria); 25 years and 
above are adults and child bearing age included as risk group for all tropical infections. 
Height and Weight-for-age z-scores (WAZ) among school children were calculated based on the WHO 
growth standards [86] .Participants with z-scores below -2 were defined as stunted and underweight. 
Binary variables of the infections were created, those individuals who were with eggs/CFA positives 
were termed as cases given the numerical number 1, and those who were found not having eggs/CFA 
negatives were termed as non-cases were given numerical number 0. Infection profile status was 
created by combining data on STH, SCH and LF for each individual to determine those with none, 
single, double, triple and multiple infections. "Any infection" was defined as presence of any 
infection among the three groups of the mentioned helminth infections. This was important due to 
the multiple effects of the anthelminthic medicines (albendazole, ivermectin and praziquantel) on 
37 
 
the studied helminths. Prevalence of infections for each disease and its profile by area, age and sex 
was determined. The number of eggs counted in stool was multiplied by a factor of 24 to obtain the 
number of eggs per gram (EPG) (as the Kato Katz template allows the microscopy of exact 41.7 mg 
of stool). Geometric Mean Intensity (GMI) of STH and schistosomiasis infection was obtained by 
logarithms transformation on the number of eggs counted per gram. 
 
Intensity of STH and schistosomiasis was classified according to WHO guidelines [87]. The 
classification of intensity for soil-transmitted helminths were as follows: A. lumbricoides (light (1-
4999 eggs/g), moderate (5000 - 49999 eggs/g) and heavy (≥ 50000 eggs/g) of stool); T. trichiura (light 
(1-999 eggs/g), moderate (1000-9999 eggs/g) and heavy (≥ 10000 eggs/g) and Hookworm ( light ( 1-
1999 eggs/g), moderate (2000-3999 eggs/g), and heavy (≥ 4000 eggs/g)). S. mansoni was classified 
into light infection if eggs counts ranged light (1-99 eggs/g, and moderate infection if eggs count 
ranged 100-399 eggs/g and heavy infections more than 400 eggs/g of the stool (EPG).  
S. haematobium was categorized as light infection if eggs counts in urine ranged 1-49 eggs/10ml and 
heavy infection if eggs count is greater than 50 eggs/10ml.  
Anaemic individuals were classified as follows: Children age 5-11 years who had haemoglobin level 
(Hb) less than 11.5g/dL; those 12-14 years who had Hb less than 12g/dL; Non-pregnant women aged 
15 and above who had Hb less than 12g/dL and men aged 15 and above who had Hb less than 
13g/dL[88]. Eosinophilia was defined as White Blood Cell (WBC) counts which is greater than 7% of 
eosinophilic leukocytes [21]. An association of level of eosinophil count with single and multiple 
infections was determined.  
For Skin Prick tests; Only SAC were tested in 2014 and only valid tests with positive and negative 
control were included in the analysis. Binary variables of the skin prick test were created for each 
allergen including positive and negative control, those individuals who had an induration of with 
diameter more than 3mm were termed as cases given the numerical number 1, and those who had 
an induration less then 3mm diameter were termed as non-cases were given numerical number 0 
[89].  
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3.7.2. Determining the association between infection status and other variables 
Both univariate and bivariate analysis were done to explore the data and finding out relationship 
between two variables. The degree of association was obtained using chi-square test at 5% level of 
significant (p-value<0.05). Multivariate logistic analysis taking districts under survey as the random 
effects was done to find out the effect of helminths infections on the risk of stunting, underweight 
and anaemia adjusted by age group, sex, area (urban vs rural) nutritional status and infection 
prevalence. Akaike Information Criterion (AIC) a tool that compares different models given the same 
data was used to select the model that best balances drawbacks. The model with the lowest AIC 
score was selected as a best fitted model [90]. Thereafter, null -hypothesis testing was used on the 
best model to determine the relationship between specific variables and the outcome of interest. 
Multivariate logistic regression results were considered significant for p<0.05.  
For Skin prick test, a random effects logistic regression analysis was done. The analysis took into 
account the D.farinae, D.pteronnyssinus and cockroach allergen as the outcome variables and 
treated districts as the random effect of the model. This was done on the infection prevalence, areas 
of residency (rural/urban), sex and age of the study participants. Similar approach was used for 
selection of the best model as above. 
 
3.8. Ethical statement 
The proposal for this research was submitted to the Medical Research Coordination Committee 
(MRCC) of the National Institute for Medical Research-Tanzania for ethical and scientific approval. 
The study was reviewed and given an approval No. NIMR/HQ/R.8a/Vol.IX/1568 dated 8th July 2013. 
An Ethical waiver was also provided by LMU in German as per University’s guidelines. Proposal 
amendment to include other districts was granted and extended to be valid till July 2017. Permission 
to publish these data was granted by the Director General, MRCC-NIMR, as per requirement 
indicated in Ethics Clearance Certificate. 
District and village authorities were informed on the survey objectives, procedures, benefits and 
risks. A locally translated parental/guardian consent form was used. The form informed 
parents/guardians and participants about the nature of the study, and that their participation was 
voluntary. The multidisciplinary, gender balanced team was identified and trained on study methods 
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to avoid bias and influence. All interviews were conducted at a place and time that was convenient 
to both study participants and interviewers using Swahili language. Efforts were made to ensure 
privacy and confidentiality during the interviews. 
3.9. Study limitation 
Skin prick tests data planned to be conducted in 2013 surveys was not collected due to late 
importation of test kits from the manufacturer. 
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4. RESULTS 
Results presented in this section include characteristics of study population, prevalence and intensity 
infections in urban and rural areas for survey 1 (2013) and survey 2 (2014). Moreover the association 
between helminth infection with nutritional status, anaemia and allergy are presented. For 
comparison reasons data included only individuals aged 5 years and above since that group was 
reached in all surveys and is the target group for preventive chemotherapy or MDA for the targeted 
diseases. 
4.1. Characteristics of the study population by year of survey. 
The demographic characteristics of the study participants in the four districts are presented in table 
1a. In 2013, 2,708 participants were sampled while in 2014, 2,431 participated. Study participants’ 
distribution by areas (rural and urban). In year 2013; 1406 (51.9%) were sampled from rural areas 
and 1302(48.0%) from urban areas. In year 2014, 987 (40.6%) participants were from rural and 1444 
(59.4%) from urban districts. By gender 1,380 (50.6%) were males and females 1338 (49.4%). In year 
2014; about 1052 (43.3%) were males and 1379 (56.7%) females, see Table 4.1. 
Participants aged 5 years to 17 years old (including ages 5 and 17) were 1,391 (56.2%) and 1,084 
(43.8%) in 2013 and 2014 respectively. 
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Table 4.1 Study population characteristic in year 2013 and 2014 
Characteristics Year 2013 n (%) Year 2014 n (%) 
Number of Participants 
 
2708 2431 
Rural 1406 (51.9) 987 (40.6) 
Kwimba  (rural district of Mwanza) 705 (26.0) 560 (23.0) 
Sengerema  (rural district of Mwanza) 701 (25.9) 427 (17.6) 
   
Urban 1302 (48.0) 1444 (59.4) 
Temeke (urban district of Dar es Salaam) 697 (25.7) 666 (27.4) 
Kinondoni (urban district of Dar es Salaam) 605 (22.3) 778 (32.0) 
   
Sex   
Male  1370 (50.6) 1052 (43.3) 
Female 1338 (49.4) 1379 (56.7) 
   
Age(n)   
5-10 years 611 (22.3) 778 (32.0) 
11-17 years  780 (28.8) 306 (12.6) 
   
18-24years 316 (11.7) 315 (13.8) 
25-49 years 706 (26.1) 733 (30.2) 
50 and above 292 (10.8) 297 (12.2) 
Total  2705 2429 
   
Study population 5-17 years, n (%) 1391 (56.2) 1084 (43.8) 
 
4.2.  Proportion of anaemia, eosinophilia and nutritional indicators by years of surveys  
In year 2013, out of 1, 391 participants aged 5 to 17 years old, 1,054 (75.8%) were tested for 
haemoglobin level while in year 2014, out of 1084 participants 581(53.6%) were sampled for 
haemoglobin level test. In 2013, those sampled from urban areas were 647 (61.4%) while rural 407 
(38.6%). In 2014; 340 (58.5%) were from urban and 241 (41.5%) were from rural areas. There was a 
notable change in mean haemoglobin from 2013 to 2014, whereby mean haemoglobin dropped 
significantly from 12.5 to 11.9g/dl, p<0.001 (table 4.2). The proportion of anaemic participants 
increased from 239/1,054 (22.7%) in year 2013 to 193/581 (33.2%) in year 2014. 
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Regarding anaemia a difference between the urban and rural areas was noted. In urban areas, the 
proportion of anemic participants dropped from 143/647 (22.1%) in year 2013 to 37/340 (10.9%) in 
year 2014, p<0.001 while in the rural areas, proportion of anemic participants increased from 96/407 
(23.6%) in year 2013 to 156/241 (64.7%), p<0.001 in year 2014. 
Two nutritional indicators were measured: Weight for age and height for age. No change for weight 
was seen from 2013 to 2014. Underweight children were found in 174/1,060 (16.4%) of the children 
in 2013 and in 156/829 (18.8%) of the children in 2014, p=0.2. 
In contrast, a significant decrease proportion of stunted participants from 273/1,009 (27.1%) in year 
2013 to 124/ 828 (15.0%) in year 2014, p<0.001, (Table 4.2). 
 
  
43 
 
Table 4.2 Proportion of participants tested for blood and anthropometric indicators by year of surveys in 
rural and urban areas 
 Characteristics Year 2013  Year 2014  Test Statistics &P value 
Study population 5-17 years 1391 1084  
Number tested for Hb, n (%) 1054 (75.8) 581 (53.6)  
Areas Urban n (%) 647 (61.4)  340 (58.5)  
 Rural (%) 407 (38.6) 241 (41.5)  
Mean Haemoglobin level: n (mean) 1054 (12.5) 581 (11.9) t-test=7.6, p<0.001 
Anaemia status n (%) Normal 815 (77.3) 388 (66.8) 
Χ²₁ =21.4, p<0.001  Anaemic 239 (22.7) 193 (33.2) 
Anaemia category=n (%) None 815 (77.3) 388 (66.8)  
 Mild 143 (13.6) 107 (18.4)  
 Moderate 87 (8.3) 81 (13.9)  
 Severe 9 (0.9) 5 (0.9)  
only urban areas only urban areas    
Mean Haemoglobin level: n (mean) 647 (12.69) 340 (12.63) t-test=0.8, p=0.4 
Anaemia status n (%)  Normal 504 (77.9) 303 (89.1) 
Χ²₁ =18.8, p<0.001  Anaemic 143 (22.1%) 37 (10.9) 
Anaemia category=n (%) None 504 (77.9) 303 (89.1)  
 Mild 91 (14.1) 19 5.6)  
 Moderate 46 (7.1) 81 (4.7)  
 Severe 6 (0.9) 2 (0.6)  
only rural areas only rural areas    
Mean Haemoglobin level: n (mean) 407 (12.3) 241 (11.1) t-test=12.4, p<0.001 
Anaemia status n (%) rural Normal 311 (76.4) 85 (35.3) 
Χ²₁ =107.8, p<0.001  Anaemic 96 (23.6%) 156 (64.7) 
Anaemia category=n (%) None 311 (76.4) 85 (35.3)  
 Mild 52 (12.8) 88 (36.6)  
 Moderate 41 (10.1) 65 (27.0)  
 Severe 3 (0.7) 3 (1.2)  
Eosinophilia (>7%) Normal 714 (69.2) 411 (94.5) 
Χ²₁ =109.5, p<0.001  High 318 (30.8) 24 (5.5) 
Nutritional status     
 
Weigh for Age (WAZ) Normal 886 (83.6) 673 (81.2) 
Χ²₁ =109.5, p=0. 2 
 Underweight 174 (16.4) 156 (18.8) 
Height for Age (HAZ) Normal  736 (72.9) 704 (85.0) 
Χ²₁ =109.5,p<0.001 
Stunted Stunted 273 (27.1) 124 (15.0) 
 
    
 
Regarding eosinophilia, a potential surrogate marker for helminth infection, a significant drop from 
318/1032 (30.8%) in 2013 to 24/435 (5.5%) in 2014 was noticed (p<0.001). 
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4.3. Prevalence of helminth infections by year of survey 
A total 752 and 804 participants aged 5-17 years old were tested for stool in year 2013 and 2014 
respectively while for urine the numbers examined were 749 and 804 in year 2013 and 2014 
respectively. 
4.3.1. Schistosoma haematobium infection prevalence 
Overall prevalence in 2013 was 73/749 (9.8%). No cases were found in urban areas. In rural areas, 
73/403 (18.1%) were infected. Further analysis of sex and age distribution was performed only for 
rural areas. The prevalence was higher among males’ participants 47/369 (12.8%) compared to 
females 26/380 (6.8%) p<0.001. Age wise participants aged 11 – 17 years old had with 49/416 
(11.8%) a higher prevalence compared to 5-10 years olds were 24/333 (7.2%), p=0.04 were S. 
haematobium were positive  
In year 2014, 22 of the participants were found to have S. haematobium infection as before (all in 
rural areas) leading to a prevalence of 22/406 (5.4%). A significant crude reduction of 74% (95% CI 
57%-84%, p<0.001) of S. haematobium infection from 2013 to 2014, was noted. The drop in 
prevalence was seen in all subgroups: Prevalence in males dropped from 47/369 (12.8%) to 9/ 386 
(2.3%), reduction of 84% (95% CI 66% to 93.0%, p<0.001. Females dropped from 26/380 (6.8%) to 
13/ 418 (3.1%), reduction of 57%, 95% CI, 14 to 78%, p=0.015. Among participants aged 11 – 17 years 
old the prevalence dropped from 49/416 (11.7%) to 9/199 (4.5%), p<0.001.The drop in prevalence 
of infection was also noted among participants 5-10 years old from 24/333 (7.2%) in 2013 to 13/605 
(2.1%) p<0.001 in the year 2014.  
4.3.2. Schistosomiasis mansoni infection prevalence 
In 2013, overall 11/752 (1.5%) participants were infected. There was no case in urban areas. 
Participants from rural areas had a prevalence of 11/406 (2.7%), of these 11 infected 5/383 were 
females (1.3%) and 6/ 369 (1.6%) were males (table 4.3a). The difference in prevalence of infection 
between males and females was not statistically significant with p=0.5. Likewise there was no 
significant difference in infection among age groups (Table 4.3a). 
In year 2014, overall there was no significant change in infection prevalence of S. mansoni from year 
2013 (Table 4.3b). 
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4.3.3.  Hookworm infection prevalence 
 In 2013, the overall prevalence of hookworm infection 21 /752 (2.8%).One 1 /346 (0.3%) was from 
urban and 20/ 406 (4.9%) were from rural areas, p<0.001. The infected participants in urban areas 
was a female in the age group 11-17 years old while those in the rural areas were evenly distributed: 
10/182 (5.5%) were males, and 10/224 (4.5%) were females, p=0.6. Those aged 5-10 years were 8/ 
193 (4.2%) and aged 11-17 years were 12/ 213 (5.6%), p=0.5. Therefore, neither gender nor age 
groups showed evidence on differences in prevalence of hookworm infection (Table 4.3a) 
In 2014, overall 17/804 (2.1%) had hookworm infection indicating no significant drop from year 
2013, where the prevalence was 21/752 (2.8%), p=0.4. In 2014, there were no participants infected 
in urban areas. Among the participants infected with hookworm of the rural areas, 8/207 (3.9%) 
were females and 9/199 (4.5%) were males (Table 4.3b). 
 
Table 4.3a Prevalence of helminth infections in year 2013 by areas (rural /urban), sex and Age 
    Areas Sex Age  
  Variables Urban Rural Female  Male   5 to 10 years 10  to 17 years  
 Total 346 403 380 369 333 416 
S.haematobium Cases 0 95 26 47 24 49 
 Prevalence 0.0 23.6 6.8 12.7 7.2 11.8 
 Test statistics p<0.001 p=0.007 p=0.04 
    
 
   
 Total 346 406 383 369 335 417 
S.mansoni Cases 0 11 5 6 3 8 
 Prevalence 0.0 2.7 1.3 1.6 0.9 1.9 
 Test statistics p<0.001 p=0.7 p=0.2 
        
 Total 346 406 383 369 335 417 
Hookworm Cases 1 20 11 10 8 13 
 Prevalence 0.3 4.9 2.9 2.7 2.4 3.1 
  Test statistics p<0.001 p=0.9 p=0.5 
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Table 4.3b: Prevalence of helminth infections in year 2013 and 2014 by district 
Infection  areas   Year 2013 Year 2014 Test Statistics &P value 
S.haematobium Urban  Number examined  346 398 
    Cases 0(0.0) 0(0.0) 
 Rural Number examined  403 406 
Χ²₁ =31.5, p<0.001   Cases 73(18.1) 22(5.4) 
S.mansoni Urban  Number examined  346 398  
  Cases 0(0.0) 0(0.0) 
 Rural Number examined  406 406 
Χ²₁ =3.3, p=o.07   Cases 11(2.7) 4(1.0) 
hookworm Urban  Number examined  346 398 
Χ²₁ =1.2, p=0.3   Cases 1(0.3) 0(0.0) 
 Rural Number examined  406 406 
Χ²₁ =0.3, p=0.6   Cases 20(4.9) 17(4.2) 
LF (all) Urban  Number examined  1275 1358 
Χ²₁ =0.06, p=0.8   Cases 29(2.3) 29(2.1) 
 Rural Number examined  1406 963 
Χ²₁ =0.5, p=0.4 
    Cases 16(1.1) 8(0.8) 
      
 
4.3.4. Malaria  
The malaria tests were performed for the age group 5-17 years old. 
In 2013, total 1,054 were tested for the presence of malaria parasites in their blood, out of these 10 
(1.0%) were found to have malaria parasites from both rural and urban settings. Out of 647 tested 
were from urban and only 1 (0.2%) was found to be positive. The prevalence was 9/407 (2.2%) for 
the rural areas. There was no difference of malaria infection neither between age groups nor 
between males and females for year 2013.  
In year 2014, a total of 648 participants were sampled and 62 (9.6%) of them were found to have 
malaria parasites. There was a 10 folds increase in the prevalence of Malaria in year 2014 compared 
to 2013, p<0.001. Moreover in 2014, all 62 positive cases were from rural areas, were the prevalence 
rose from 9/407 (2.2%) to 62/308 (20.1%) from 2013 to 2014. No sex and age group differences in 
prevalence of malaria were observed as in year 2013. 
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4.3.5. Lymphatic Filariasis (LF) infection prevalence 
LF was tested in blood samples of individuals aged 5 to 92 years of age. 
In 2013, a total 2,681 were tested for LF using CFA, out of these 45/ 2,681 (1.7%) were found to have 
positive antigenemia in both rural and urban settings, of these urban participants were 29/1,275 
(2.3%) while rural were 16/ 1,406 (1.1%),p=0.02; indicating a higher prevalence of LF infection in 
urban areas than in rural areas. The prevalence of infection was not significant between males 27/ 
1,360 (2.0%) and female 18/ 1,321 (1.4%) p=0.2. The prevalence of infection was noted to increase 
with age. 
In year 2014, a total of 2,321 participants were sampled and 37/ 2,321 (1.6%) of them were found 
to have LF infection. No significant change of LF infection was observed between the 2 surveys in 
terms of areas of residence, and gender. Moreover in 2014, a total 29/ 1,358 (2.1%) were from urban 
areas while 8/ 963 (0.8%) were from rural areas, p=0.013. It was also noted that participants aged 
18-24 years had a highest prevalence 14/305 (4.6%) compared to other age groups. (Figure 4.1 
prevalence trend by years). Comparing the overall LF prevalence in year 2013, 45/2,681 (1.7%) and 
year 2014, 37/2,321 (1.6%) no major change was seen. However, separating between age groups an 
increase in LF prevalence from 6/313 (1.9%) to 17/305 (4.6%), p=0.06 was seen, and a decrease 
among the over 50 year olds from 11/290 (3.8%) to 3/294 (1%), p=0.003.  
 
Figure 4.1: Prevalence of LF by age and year of survey 
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4.4. Helminth Infection intensity by years of surveys 
4.4.1. S. haematobium intensity 
Overall prevalence in 2013 was 73/749 (9.8%), 64/749 (8.5%) were categorized of having a light 
infection (between 1 and48 eggs/10ml of urine) and 9/749 (1.2%) were heavy infected (egg count 
between53 and 118eggs /10ml of urine). 
Overall Geometric Mean intensity (GMI) in 2013 was 10.4 (95% CI; 7.7-14.1) eggs /10ml of urine 
among infected participants.  
In 2014, GMI intensity was 7.8 (95%CI 5.4-11.2) eggs /10ml of urine among infected participants in 
rural areas. Findings revealed no overlap in confidence intervals indicating non-significant drop in 
intensity from 2013 to year 2014, p=0.1 (Figure 4.2). Moreover no heavy infected participants were 
found and those with light infections were 22/804 (2.7%). 
4.4.2.  S. mansoni intensity 
S. mansoni infection was diagnosed in 11 participants in 2013, of which four 4/752 (0.5%) 
participants had light infection and 7/752 (0.9%) had heavy infection. The egg count ranged from 
12/gram to 9600/gram with an overall GMI of 410.8 (95% CI: 85.4-1975.3) epg among infected 
participants. 
In the year, 2014, all infected participants had light infections. The GMI was 40.4 (95% CI: 14-116.0) 
epg. The drop in GMI from year 2013 to 2014, was statistically significant, p=0.01 (Figure 4.3). 
4.4.3. Hookworm Intensity 
In 2013, Geometric Mean intensity of those infected with hookworm infection was 318 (181.3-558.3) 
epg. All infected had light infections.  
In 2014, rural areas the GMI dropped to 70.7 epg (51.0-98.0) while no was infections were seen in 
the urban areas. Findings indicate a significant reduction in intensity of infections from 2013 to 2014, 
p<0.001 (Figure 4.3). 
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Figure 4.2: Intensity of S. haematobium in rural areas and by year of survey 
 
 
Figure 4.3: Intensity of hookworm and S. mansoni in rural areas by years of survey. 
0.0
2.0
4.0
6.0
8.0
10.0
12.0
14.0
16.0
Rural
G
M
I e
gg
s/
1
0
m
l 
GMI2013 GMI2014
0.0
500.0
1000.0
1500.0
2000.0
2500.0
S.mansoni Hookworms
G
M
I(
 e
gg
s/
gr
am
)
GMI 2013 GMI20114
50 
 
4.5. Nutritional Indicators and Anaemia before and after MDA (CRUDE). 
4.5.1. Stunting before and after MDA 
Compared to the findings observed in the 2013 survey the results regarding health indictors in the 
2014 survey showed an overall prevalence of stunting among 770 participants tested to be 115 
(15.0%) compared with the 165/746 (22.1%) stunted individuals in 2013, this represents a crude 
reduction of 38% (95%CI: 19-53%, p<0.001). The crude reduction of stunting in females and males 
was 37% (95%CI: 0. 6-57%, p=0.02) and 39% (95%CI 13-57%, p=0.006) in 2013 and 2014 years 
respectively, and with that no difference between the gender. There was no significant change in 
stunting between age groups between 2013 and 2014 surveys. The reduction was also noted in 
participants from urban and rural areas as shown in table 5a. However, there was no significant 
change observed in stunting among participants infected with S. haematobium, S .mansoni and 
hookworms (table 4.4a). 
Table 4.4a: Stunting with helminth infection sex and age:  Comparison of 2013 and 2014 
Variables 
Number 
examined 
% positives 
(year 2013) 
Number 
examined 
% positives 
(year 2014) 
Odds 
ratio 
95% CI*  P value 
                
overall  746 165 (22.1) 770 115 (15.0) 0.62 0.47 to 0.81 p<0.001  
       
Sex        
   female  380 70 (18.4) 400 50 (12.5) 0.63 0.43 to 0.94 p=0.02 
   male  366 95 (26.0) 370 65 (17.6) 0.61 0.43 to 0.87 p=0.006 
Age         
    5 to 10 years 333 43 (12.9) 582 59 (10.1) 0.76 0.50 to 1.16 p=0.199 
   10  to 17 years  413 122 (29.5) 188 56 (29.8) 0.95 0.69 to 1.48 p=0.95 
Areas        
   urban 344 70 (20.4) 394 49 (12.4) 0.55 0.37 to 0.83 p=0.004 
   Rural 402 95 (23.7) 376 66 (17.6) 0.69 0.48 to 0.98  p=0.04 
        
S. haematobium        
   negative 674 148 (22.0) 750 111 (14.8) 0.62 0.47 to 0.81  p<0.001 
   Positive 72 17 (23.6) 20 4 (20.0) 0.81 0.24 to 2.77 p=0.74 
S. mansoni        
   negative 735 161 (21.0) 768 114 (14.8) 0.62 0.48 to 0.81 p<0.001 
   Positive 11 4 (36.4) 2 1 (50.0) 1.75 0.07 to 41.7 p=0.73 
Hookworm        
   negative 725 156 (21.5) 754 110 (14.6) 0.62 0.48 to 0.82 , p<0.001 
   positive 21 9 (42.9) 16 5 (31.3) 0.61 0.15 to 2.44 p=0.48 
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4.5.2. Comparison of underweight before and after MDA. 
In the 2014 survey the overall prevalence of underweight was 143 (18.6%) out of 771 participants 
indicating a crude increase in risk of underweight by 1.47 (95% CI 1.11.-1.96, p=0.006) times 
compared to year 2013. Among females the risk increased by 1.51 (1.0-2.28, p=0.047) times while 
among males the prevalence increased by 1.45%. (95% CI: 0.99-2.13, p=0.052). Similarly, in both 
age groups a notable increase in risk of underweight was observed. The risk of underweight 
increased significantly among residents of urban areas in 2014 by 3.38 (95% CI: 1.88-6.06, p<0.001) 
times more compared to year 2013 while in the rural areas the increased risk of underweight was 
not significant. There was no significant reduction in the prevalence of underweight among 
participants with helminth infections (S. haematobium, S. mansoni and hookworms) from 2013 to 
2014 as shown in table 4.4b 
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Table 4.4b: Underweight with helminth infection, sex and age:  Comparison of 2013 and 2014 
 
Indicator 
Number 
examined 
% positives 
(Year 2013) 
Number 
examined 
% positives 
(Year 2014) 
Odds 
ratio 
95% CI*  P value 
overall  748 100 (13.4) 771 143 (18.6) 1.47 1.11 to 1.95  p=0.006  
       
Sex        
   female  379 44 (11.6) 398 66 (16.6) 1.51 1.00 to 2.28 p=0.047 
   male  369 56 (15.2) 373 87 (20.6) 1.45 0.99 to 2.13 p=0.052 
Age         
    5 to 10 years 333 25 (7.5) 584 86 (14.7) 2.13 1.33 to 3.41 p=0.0013 
   11  to 17 years  415 75 (18.1) 187 57 (30.5) 1.99 1.33 to 2.98 p=0.0007 
Areas        
   urban 346 16 (4.6) 391 55 (14.1) 3.38 1.88 to 6.06 p<0.001 
   rural 402 84 (20.9) 380 88 (23.2) 1.14 0.81 to 1.60 p=0.445 
        
S. haematobium        
   negative 675 83 (12.3) 751 140 (18.6) 1.63 1.21 to 2.19 p<0.001 
   positive 73 17 (23.0) 20 3 (15.0) 0.58 0.15 to 2.25 p=0.427 
S. mansoni        
   negative 737 96 (13.0) 767 142 (18.5) 1.52 1.14 to 2.01 p=0.004 
   Positive 11 4 (36.4) 4 1 (25.0) 0.58 0.04 to 8.51 p=0.69 
Hookworm        
   negative 727 93 (12.8) 754 141 (18.7) 1.57 1.18 to 2.09 p=0.002 
   positive 21 7 (33.3) 17 2 (11.8) 0.27 0.04 to 1.64 p=0.12 
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4.5.3. Anaemia before and after MDA 
Table 4.5c shows the distribution of anaemia by study variables across the two surveys. The overall 
prevalence of anaemia was 21.4% and 34.6% in 2013 and 2014 respectively (p<0.001). A 2.9 (95% 
CI: 1.96-4.19, p<0.0001) times increase in the risk of being anaemic was seen among female 
participants comparing year 2013 and 2014, significant. For male participants the increase in anemia 
was 1.3 times, and with that not significant (p=0.05). An analysis of the age groups indicated the risk 
of being anaemic significantly increased for the younger 5-10 year olds as well as for the 11 till 17 
year olds. The analysis of the residential areas showed a divergent trend. There was a significant 
increased risk of anemia in rural areas from 2013 to 2014 by 6 times (95% CI: 4.07-8.06, p<0.001) 
while in urban areas the prevalence of anaemia reduced significantly by 47 % (95% CI: 17-67%, 
p=0.005) times. For the helminths it was seen, that for S. mansoni the infected and uninfected group 
showed similar increase in risk, but for S. haematobium and Hookworm the infected individuals 
showed a more dominant change. Table 4.4c. 
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 Table 4.4c: Anaemia with helminth infection, malaria, sex and age:  Comparison of 2013 and 2014 
  year 2013                    year 2014       
Variables 
Number 
examined 
Positive  Number 
examined 
Positive  Odds 
ratio 
95% CI*  P value 
(%) (%) 
overall  749 160 (21.4) 526 182 (34.6) 1.95 1.51 to 2.51 p<0.001 
Sex        
   female  380 59 (15.5) 284 98 (34.5) 2.87 1.96 to 4.19 p<0.0001 
   male  369 101 (27.4) 242 84 (34.7) 1.41 0.99 to 2.00 p=0.054 
Age         
    5 to 10 years 333 49 (14.7) 409 138 (33.7) 2.95 2.03 to 4.30 p<0.001 
   10  to 17 years  416 111 (26.7) 117 44 (37.46) 1.66 1.06 to 2.39 p=0.022 
Areas        
   Urban 346 65 (18.8) 295 32 (10.9) 0.43 0.29  to 0.83 P<0.001 
   Rural 403 95 (23.6) 231 150 ( 64.9) 6 4.07  to 8.86 p<0.001 
        
S. haematobium        
   Negative 676 137 (20.3) 511 171 (33.5) 1.98 1.52 to 2.58 p<0.001 
   Positive 73 23 (31.5) 15 11 (73.3) 5.98 1.59 to 22.5 p=0.003 
S. mansoni        
   Negative 738 156 (21.1) 522 180 (34.5) 1.96 1.52 to 2.54 p<0.001 
   Positive 11 4 (36.4) 4 2 (50.0) 1.75 0.16 to 19.54 p=0.645 
Hookworm        
   negative 728 152 (20.9) 516 174 (33.7) 1.93 1.49 to 2.50 p<0.001 
   Positive 21 8 (38.1) 10 8 (80.0) 6.5 0.91 to 46.58 p=0.032 
Malaria        
   negative 740 156(21.1) 481 140(29.1) 1.54 1.18 to 2.00 p<0.001 
   Positive 9 4(44.4) 45 42(93.3) 17.5 2.20 to 138.7 p<0.001 
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4.6.  Association between helminth infections with Nutritional status and Anaemia  
4.6.1. Association of Stunting with sex, age, area and helminth infections  
Overall, among 1519 participants tested, 283 (18.6 %) were stunted. Of the 781, females were 121 
(15. 5%) and 162of the 738 males (21.9%), p=0.01 were stunted. Adolescents aged 11-17 years were 
3.4 (95% CI; 2.5-4.4-.p<0.001) times more likely to be stunted than those aged 5-10 years Rural 
participants were 1.4(95% CI; 1.0-1.4-.p=0.02) times more stunted compared to urban participants. 
Regarding helminth infections, no association of stunting was found for S.haematobium while for 
S.mansoni and hookworm infected participants both were 2.8 times more at risk of being stunted. 
Multilevel logistic regression analysis with districts of survey as random effect revealed that the risk 
of being stunted was 2.3 (95%CI; 1.1-4.6, p=0.03) times among participants infected with 
hookworms adjusted by year of survey, sex, age and area of residence (rural or urban). In contrast, 
it was observed that the risk of being stunted was not associated with schistosomiasis. Participants 
aged 11-17 years were 3 (96% CI; 2.3-4.0, p<0.001) times more at risk of being stunted adjusted by 
area, year of survey and infection table 4.5a.  
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Table 4.5a. Association of Stunting with age, sex, areas years and helminth infections 
Variable 
  
Univariate 
  
Multivariate 
  
Total 
Number 
examined 
=1516 
Odd Ratio(95% CI) P-value 
Odd Ratio(95% 
CI) 
P-value 
Age (yrs) 5-10 yrs 915         
  11-17 yrs 601 3.4(2.5-4.4) p<0.001 3.0 (2.3-4.0) p<0.001 
Sex Female 780         
  Male 736 1.5(1.2-1.9) p<0.001 1.3(0.9-1.7) p=0.08 
areas    Urban 738         
   Rural 778 1.4(1.04-1.8) p=0.02 1.3(0.9-2.1) P=0.20 
years 2013 746         
  2014 770 0.47(0.37-0.60) P<0.001 0.8(0.6-1.1) 0.3 
S. haematobium 
Negative 1424         
Positive 92 1.3(0.8.2.2) P=0.3 0.8(0.5-1.4) 0.4 
S. mansoni 
Negative 1503         
Positive 13 2.8(0.9-8.6) P=0.059 1.5(0.5-5.1) 0.5 
Hookworms 
Negative 1479         
Positive 37 2.8(1.4-5.5) P=0.002 2.3(1.1-4.6) 0.03 
 
4.6.2. Association of underweight with age, sex, areas and helminth infections 
The overall prevalence of underweight was 243(16.0%) out of 1519 participants. Females were 110 
(14.2%) while males were 133 (17.9%). There was a significant difference in prevalence between the 
two analyzed 2 age groups; those 11-17 years old was 2.0 (95% CI: 1.5-2.7, p<001) times more likely 
to be underweight compared to those aged 5-10 years old, The prevalence of underweight was 
highly associated with area of residence whereas; those living in rural areas being 2.6 (95% CI: 2.0-
3.6, p<0.001) times more likely to be stunted. There was no significant association between 
underweight and all the three infections in univariate and multivariate analysis. Multilevel logistic 
regression analysis with districts of survey as random effect revealed that the risk of being  
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underweight was 2.6 (95%CI; 1.9-3.5, p=0<0.01) times more in those aged 11-17 years old and 2.7 
(95%CI , 2.0-3.6) times more in rural areas and 2.1(95%CI, 1.5-2.9,p<0.001) times more in 2014 
adjusted by year of survey, sex, age and area of residence (rural or urban).Table 4.5b. 
Table 4.5b: Associations of Underweight with sex, age area and helminth infection  
Variable 
       
Number 
examined 
=1519 
Univariate Multivariate 
Odd 
Ratio(95% CI) 
P-value 
Odd Ratio(95% 
CI) 
P-value 
Age (yrs) 5-10 yrs 917 1.0    
  11-17 yrs 602 2.0(1.5-2.7) p<0.001 2.6(1.9-3.5) p<0.001 
Sex Female 777 1.0    
  Male 742 1.3(1.0-1.7) P=0.046   
Areas    urban 737 1.0    
   Rural 782 2.6(2.0-3.6) p<0.001 2.7(.2.0-3.6) p<0.001 
Years 2013 748 1.0    
  2014 771 1.5(1.1-1.9) p=0.006 2.1 (1.5-2.9) p<0.001 
S. haematobium Negative 1426 1.0    
  Positive 93 1.5 (0.9-2.5) p=0.137   
S. mansoni Negative 1504 1.0    
  Positive 15 2.7(0.9-7.9) p=0.077   
Hookworms Negative 1481 1.0    
  Positive 38 1.7(0.8-3.5) p=0.19   
              
 
4.6.3. Association of Anaemia with age, sex, areas, helminth infections and Malaria  
Out of 1275 participants examined 342 (26.8%) were anaemic. Males were 1.4 (95% CI; 1.1-1.8, 
p<0.008) times more likely to be anaemic than females. Rural areas participants were 3.5(95% CI; 
2.7-3.7, p<0.001) and 1.9(95% CI, 1.5-2.5) times more in year 2014. Moreover, participants infected 
with S. haematobium were 1.8 (95% CI: 1.2-2.8 p=0.009) times more at risk of being anaemia than 
those non- infected. A notable non-significant association between anaemia and S. mansoni and 
hook infection prevalence was observed. Malaria infected individuals were 18 (95% CI, 8.9-39.7, 
p<0.001) times more at risk of being anaemic compared to those with no malaria infected 
participants. 
The major impact on anaemia was seen through malaria. There was an increase in malaria cases 
from 2013 to 2014. As a result there was a rise in prevalence of anemia in the respective area. 
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Individuals infected with plasmodia were found to be 7.8 times more likely to be anaemic. Overall, 
after adjusting for age, area of residence, sex and nutritional status the risk of being anaemic was 
2.4 (95% CI; 1.8-3.2, p<0.001) times more in year 2014 compared to year 2013. The risk of being 
anaemic was higher among rural participants by 3.5(95% CI; 2.5-4.5, p<0.001) times compared to 
urban participants adjusted by age, sex, year of survey and nutritional status. Moreover males were 
1.4 (95%CI; 1.1-1.9-2, p=0.012) times anaemic in a multivariate analysis adjusted by other variables 
as shown in the table 4.5c.  
Table 4.5c: Association between anaemic with sex, age area year, helminth infections and Malaria   
Variable 
Total 
Number 
examined 
=1275 
Univariate Multivariate 
Odd 
Ratio(95% CI) 
P-value Odd Ratio(95% CI) P-value 
Age (yrs) 5-10 yrs 742 1.0       
  11-17 yrs 533 1.2(0.9-1.6) p=0.12 1.5(1.2  -2.1) p=0.004 
Sex Female 664 1.0       
  Male 611 1.4(1.1-1.8) p=0.0076 1.4(1.1-.1.9 p=0.012 
  Areas    Urban 641 1.0       
   Rural 634 3.5(2.7-4.7) p<0.001 3.4(2.5-4.5) p<0.001 
Years 2013 749 1.0       
  2014 526 1.9(1.5-2.5) p<0.001 2.4(1.8-3.2) p<0.001 
S. haematobium Negative 1,187 1.0       
  Positive 88 1.8(.1.2-2.8) 0.009     
S. mansoni Negative 1,260 1.0       
  Positive 15 1.8(0.6-5.2) 0.24     
Hookworm Negative 1244 1.0       
  Positive 31 3.0(1.5-6.2) p=0.0016     
Malaria Negative 1221 1.0       
       
  Positive 54 18(8.9-39.7) p<0.001 7.8(3.5-17.1) p<0.001 
  
4.7. Multiple helminth infections profiles by years of surveys  
The infection profile with helminthiases involved parasitological examination of 749 participants 
aged 5 to 17 years old in 2013 and 743 in 2014. The infection profile for 2013 was as follows: 
participants with single helminth infections were 90 (12.0%); double infections were 8 (1%) while 
only 1 (0.7%) participant was found with triple infections. Single infections found were S. 
haematobium 68 (8.7%), S. mansoni 8 (1.1%), hookworms 13 (1.7%) and LF 4 (0.5%). Double 
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infections were of three combinations; S. haematobium and S. mansoni; S. haematobium and 
hookworm and S. mansoni and hookworm. The distribution is as shown in the table 4.6.  
In the 2014 survey, the helminthes infection profiles were single 38 (5.1%) and double were 3 (0.4%). 
There were no triple infections observed. A notable crude reduction of single infected participants 
by 60.1% (95% CI; 41.3%-73.5%, p<0.001) in year 2014 compared to 2013 was observed. For double 
infections a non-significant crude reduction was observed. Participants infected with at least one of 
helminthiases among LF, hookworm, S. mansoni and S. haematobium herein referred to as “any 
infection” in the 2013 survey a higher prevalence 99 (13.2%) compared to the prevalence of at least 
one infection 41 (5.5%) in year 2014, (p<0.001). The crude reduction rate of at least any infection in 
year 2014 was 61. 7% (95%CI; 43.8%-73.8%, p<0.001). 
Table 4.6: Helminths infection profiles by year of survey (before and after MDA) 
 Year 2013 Year 2014 
Variables Prevalence (n=749) Prevalence (n=743) 
None  650 (86.8) 702 (94,5) 
single  90 (12.0) 38 (5.1) 
Double  8 (1.0) 3 (o.4) 
Triple  1 (0.1) 0 (0.0) 
Diseases  profiles   
None  650 (86.8) 702 (94,5) 
 S. haematobium  68 (8.7) 17 (2.3) 
S. mansoni 8 (1.1) 3 (0.4) 
Hookworm 13 (1.7) 14 (1.9) 
LF 4 (0.5) 4(0.5) 
 S. haematobium + S. mansoni  1(0.1) 0(0.0) 
 S. haematobium + Hookworm  6 (0.8) 2 (0.3) 
S. mansoni + Hookworm 1(0.1) 1 (0.1) 
S. haematobium + S. mansoni +Hookworm 1 (0.1) 0 (0.0) 
   
Any infection 99 (13.2) 41 (5.5) 
 
4.8. Correlation of “any infection” with nutritional status and anaemia 
The proportion of helminth infection on nutritional markers was analyzed for both years.  
In 2013, 165 individuals were defined as stunted and 27 (16.4%) of them suffered from a helminth 
infection. In 2014 this dropped to 9/105 (8.6%), showing a non-significant crude change, p<0.07. 
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Proportion of underweight among participants with any infection was 24/100 (24.0 %) in 2013 and 
significantly dropped to 6/135 (4.4%) in 2014 (p<0.001). For anaemia findings indicated that the 
prevalence of participants with any infection and anaemic was 33/160 (20.6%) in 2013, and 
significant reduced to 22/174 (12.6%), p=0.05.  
When adjusting for sex, age, stunting, anaemia year of survey and taking district as random effect in 
the model; the prevalence of participants with any infection, significantly reduced by 63% (95% CI: 
36%-78%, p<0.001) in year 2014 compared to 2013. Moreover, anaemia increased by 1.7 (95%CI: 
1.1-2.7, p=0.018) times in those participants with “any infection” helminth infections adjusted by 
year of survey, sex, nutritional status and anaemia as shown in table 4.8. 
Table 4.7: Relationship between “any infection” and other co variables (adjusted) 
Type Variable No. examined Odds ratio 95% CI p_value 
Year of Survey 2013 746 1   
  2014 457 0.37 0.22-0.64 p<0.001 
Sex Female 625 1   
  Male 578 1.3 0.98 -1.99 P=0.16 
Age group 5-10 years 679 1   
 11--17 years  524 1.48 0.97-2.28 0.07 
Stunted  Normal 964 1   
  Stunted 239 1 0.62-1.62 p=0.99 
Anaemia  Normal 876 1   
  Anaemic 327 1.72 1.10-2.71 p=0.018 
Malaria Negative 1152 1   
  Positive 51 1.5 0.69-3.26 P=0.31 
  
4.9. Helminth and atopic diseases  
Dust mites’ allergens (D.farinae and D. pteronyssinus) and cockroach allergens (Blatella germanica) 
were used for Skin Prick Test (SPT) only in year 2014. The assessment was on individuals aged 5-17 
years old.  
780 participants were tested for all the 3 allergens. Forty one 38/780 (4.9%) of participants tested 
positive for D. farinae allergen. More participants aged 11-17 years 16/192 (8.3%) reacted positively 
against D. farinae than those aged 5 to 10 years 22/588 (3.7%), p=0.01. Likewise more participants 
from rural areas 31/387 (8. 0%) than urban 7/393 (1.8%) reacted positively against this allergen 
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(p<0.001). Furthermore, unadjusted to other confounding variables, our findings indicate that, 
people in rural areas were 4.8 (95% CI; 2.1 -11.1, p<0.001) times more of being reactive to D. farinae. 
Using a random effects logistic regression analysis, it was noted that those participants from ages 
11-17 years old were 2.0(95%CI; 1.0-3.9, p, 0.04) times more reactive to dust mites than younger 
ones and rural areas ones were 4.5 (95%CI; 1.9-10.4, p=0.001) times more reactive to D. farinae 
compared to those from urban areas adjusted by the effect of infections, sex and age. Only 
hookworm infected participants were 4.5 times more infected than those without infection 
(p=0.0134).  
Table 4. 8a: Associations of between D farinae atopy and age, sex, areas and helminth infections 
Variable 
  Univariate Multivariate 
Total 
Number 
examined 
=780 
Univariate   Multivariate   
Odd Ratio(95% 
CI) 
P-value 
Odd Ratio(95% 
CI) 
P-value 
Age (yrs) 5-10 yrs 588 1.0       
  11-17 yrs 192 2.3(1.9-4.6) p=0.01 2.0(1.0-3.9) p=0.04 
Sex Female 405 1.0       
  Male 375 0.6(0.3-1.2) p=0.1     
areas    Urban 393 1.0       
   Rural 387 4.8(2.1-11.1) p=0.0001 4.5(1.9-10.4) p<0.001 
S. haematobium 
Negative 760 1.0       
Positive 20 2.2(0.5-10.0) p=0.3     
S. mansoni 
Negative 776 1.0       
Positive 4 6.7(0.7-65.0) p=0.06     
Hookworms 
Negative 763 1.0       
Positive 17 4.5(1.2-16.3) p=0.0134     
 
Overall 31/780 (3.9%) participants reacted positive for D. pteronyssinus. More female participants 
23/405 (5.7%) reacted compared to males 8/375 (2.1%), p=0.01. Participants aged 11-17 years old 
12/192 (6.3%) were more reactive against this allergen and participants from rural areas 25/387 
(6.5%) were more reactive than in urban areas 6 /393 (1.5%), p<0001. Multivariate analysis, 
indicated that the risk of reacting against D. pteronyssinus was 8.4 (95%CI; 2.5-27.8), p<0.001) times 
among participants infected with hookworm compared to those without hookworm infection. Males 
were 60% (95%CI; 20% -80%, p=0.01) less of being reactive against D. pteronyssinus compared to 
females .After adjusting  for age, infections and sex rural areas were 60% (95% CI,30%-90%) less 
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prone to react for D. pteronyssinus.. Likewise rural areas and hookworm infected participants were 
4(1.6-10.1, p=0,003 and 5.8 (1.7-20-3) times more prone respectively to react against this atopy. 
Table 4.8b Associations between D. pteronyssinus atopy and age, sex, areas and helminth infections 
Variable 
Total 
Number 
examined 
=780 
Univariate Multivariate 
Odd Ratio 
(95% CI) 
P-value Odd Ratio(95% CI) P-value 
Age (yrs) 5-10 yrs 588 1.0       
  11-17 yrs 192 2.0(0.9-4.2) p=0.06 0.4(0.1-0.7) 0.011 
Sex Female 405 1.0       
  Male 375 0.4(0.2-0.8) p=0.01     
areas    urban 393 1.0       
   rural 387 4.5(1.8-11.1) p=.0004 4.0(1.6-10.1) p=0.003 
S. haematobium 
Negative 760 1.0       
Positive 20 1.3(0.2-9.9) p=0.8     
Hookworms 
Negative 763 1.0       
Positive 17 8.4(2.5-27.8) p<0.001 5.8(1.7-20.3) p=0.005 
 
 A total 56/780(7.2%) tested positive for cockroach allergen and contrary to the 2 previous SPT tests 
above, significantly more 41/393(10.4%) participants from urban areas than rural 15/387 (3.8%) 
(p<0.001). 
However our findings revealed that there was no significant association of S. mansoni, S. 
haematobium infection for that allergen as shown in (table 4.8c). None of the helminth infections 
showed an association with the skin prick test for Blatella germanica (cockroach). 
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Table4.8c: Associations between cockroach atopy and age, sex, areas and helminth infections 
Variable 
Total 
Number 
examined 
=780 
Univariate Multivariate 
Odd Ratio(95% CI) P-value 
Odd 
Ratio(95% CI) 
P-value 
Age (yrs) 5-10 yrs 588 1.0       
  11-17 yrs 192 1.8(1.0-3.2) p=0.05     
Sex Female 405 1.0       
  Male 375 0.7(0.4-1.2) p=0.2     
areas    urban 393 1.0       
   rural 387 0.4(0.2-0.6) p=0.0004 0.4(0.2-0.6) p=0.001 
S. haematobium 
Negative 760 1.0       
Positive 20 0.7(0.1-5.1) p=0.7     
Hookworms 
Negative 763 1.0       
Positive 17 1.8(0.4-7.9) p=0.5     
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5. Discussion 
5.1. General Burden and MDA for NTDS 
Helminth infections are among the NTDs which pose a threat to the health and socio-economic 
wellbeing of populations in endemic communities, with an estimated 1.7 billion people globally at 
risk of at least 1 NTD. The 17 NTDs described by WHO are infectious diseases, caused by viruses, 
fungi, bacteria and helminths. NTDs can be prevented, or even eliminated, with a simple, safe and 
effective intervention known preventive chemotherapy or mass drug administration (MDA). This fact 
has brought together policy makers and experts in the field of NTDs control to commit resources for 
their control and eventual elimination. Endemic countries have established control and elimination 
programmes and instituted treatment campaigns for that effect. Tanzania is endemic for helminthic 
infections and the entire population is at risk for at least 1 of the diseases among schistosomiases 
and STH (T. trichiura, A. lumbricoides and hookworm) with children and adults living in poverty being 
most vulnerable to infections. The country has adopted the WHO resolutions to eliminate or control 
NTDs and has since 2009 established the Neglected Tropical diseases control programme (NTDCP) 
to integrate control of NTDs including the helminth infections which were formerly controlled 
through disease specific control programmes. Recently (2013) a comprehensive resolution for 17 
NTDs was adopted. The programme is operational countrywide where by MDA activities are 
conducted with respective endemic diseases and are organized at the district level. As school age 
children are affected most by STH and schistosomiasis, they are specifically targeted for control using 
albendazole and praziquantel at least once yearly [91-93]. For LF elimination the target is to those 
aged 5 years old and above and the drugs of choice are ivermectin and albendazole, because for LF 
a different age distribution was reported with low prevalence in children. The current study aimed 
at elucidating the helminth disease burden and its association before commencement of MDA and 
after at least one round of intervention. The purpose was to inform policy decisions. 
5.2. Methodological issues 
Our study focused on helminth infections and the mass drug administration specifically for 
helminth infections. Using the cross sectional design, data was collected to provide a snapshot of 
the magnitude and intensity of helminth infections and their associations with selected health 
indicators in the study communities before and after the commencement of MDA. The cross-
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sectional studies have been extensively used for community based disease control monitoring to 
facilitate the assessment of the burden of diseases and impact of intervention at the community 
level and therefore allow planning and allocation of resources for their control. 
5.3. Data collection approaches and applications 
The methods used in the study were appropriate according to WHO recommendations. For 
determining the prevalence of LF, ICT Binax NOW® was used. This point of care test is based on the 
detection of circulating filarial antigen and is used globally for in eradication programmes. For STH 
and SCH the Kato the direct detection of helminth eggs through Kato Katz technique has been used, 
as it was described by several field studies in Africa [84] to determine the prevalence and intensity 
of the schistosomiases and STH. Of late there exits other tests for Schistosomiasis nowadays 
including the Circulating Cathodic antigen CCA) used to determine antibody against S .mansoni in 
urine. This test more sensitive than Kato Katz and it is user friendly in the field settings [94]. Kato 
Katz was used because it cuts over for other helminths as well, not only S. mansoni and hence it 
was cost effective. Moreover other serological tests were expensive and required specialized skills 
and equipment. 
The nutritional status was determined by using anthropometric measurements of height in 
centimeters and weight in kilogram by using a ruler and weighing scale respectively. For the 
relationship between allergies and helminths, skin prick test was determined by using a 
standardized HAL products (dust mites-D. farinae, D. pteronyssinus) droppers and lancets and 
cockroach (Blatella germanica) products were used. The procedure is extensively applied due to its 
safe and cost –effectiveness. Other laboratory tests like blood tests takes long and are less sensitive 
than SPT[95]. Analysis of data was appropriate using STATA version 12.  
5.4. Role of research in NTD programmes and MOH  
The NTDCP is an intervention programme of public health under the Ministry of Health, Community 
Development, Gender, Elderly and Children which conducts its activities under the coordination of 
the Directorate of Preventive Services. The programme mandates include coordination of the 
implementation of interventions related to control and elimination of NTDs. The monitoring and 
evaluation as well as operational research which aim to inform the programme about what works 
better and where to improve form an important component of programme activities. This is done in 
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collaboration with research institutes. Being part of the NTD programme and my involvement in 
monitoring and evaluation (M&E) activities for the past 10 years, I have gained experience and skills 
in formulating operational research agenda to inform the daily implementation issues of the 
programme. The knowledge and experience acquired enabled me to critically analyze performance 
data gathered by the programme staff and select the study sites in accordance to preliminary 
mapping results. In addition, it enabled me to conceive the research idea, generate the research 
questions and thus design this study.  
I developed the ideas of this thesis myself and I aimed to generate evidence of prevalence and 
intensity of PCT targeted helminths infections, its associated health indicators and impact of PCT. I 
also hoped to fill in the gap on contradictory findings on relationship between helminth infections 
with atopy, which are not addressed in governmental programmes, but require research interest. 
Because of the limited time for the PhD field work, after applying for and receiving ethical approval, 
and leaving time for analysis, the impact of MDA on helminth and its associated indicators was 
assessed prior and after only one round of MDA.  
5.5. Discussion of the results  
5.5.1. The prevalence of NTDs and helminths 
This study has shown predominance of infections with S. haematobium. Although there were 
considerable reductions in all infections after one round of Preventive Chemotherapy (PCT) the 
infections with S. haematobium still persisted especially in the rural areas. Similar findings of 
S.haematobium predominance have been reported in the review done in Sub- Saharan Africa which 
indicated a larger populations suffering from complications related to infections of S. haematobium 
than those with S. mansoni [7, 96, 97]. The results reported by Lwambo et al., indicted the spreading 
of S. mansoni in areas close to Lake Victoria while S. haematobium being evenly distributed 
elsewhere [76].  
Among the STH, this study has shown the dominance of hookworm infections compared to other 
worms. Previous studies conducted in Tanzania and other Sub-Saharan Africa countries have 
reported same hookworm dominance among helminthiases [7].  
There was neither T. trichiura nor A. lumbricoides infections in the four chosen survey areas. Lwambo 
et al. in 1999 also found rare Trichuris and Ascaris infections in Tanzania [76]. Recent publications 
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from Southwest Tanzania described areas with T. trichiura and A. lumbricoides; however lower 
prevalence compared with hookworm infections and patchy distribution was shown [98, 99]. 
Contrary to our findings, studies in Congo and West Africa reported predominance of T. trichiura and 
A. lumbricoides infections [100, 101] in comparison with other worms. The variability in species 
prevalence is due to geospatial and ecological factors including water resources and development 
management [76, 99, 102, 103]. Emerging findings are consistent with that of Mabaso et al. (2004), 
which showed the linkage between hookworm and soil porosity, whereby, sandy soil was reported 
to be favorable for hookworm development [104]. 
5.5.2. Helminth infections prevalence burden level 
Helminths infections still pose a big challenge to public health and socio-economic wellbeing of 
endemic communities. During baseline survey in year 2013, prevalence of LF, S. haematobium, S. 
mansoni and hookworm was lower in both rural and urban districts in comparison with preliminary 
studies of the governmental NTD control programme [70] which indicated estimated prevalence of 
< 6 % for LF and 23% to 38% for S. haematobium in Mwanza districts. For Dar es Salaam, estimates 
from NTDCP indicated that LF prevalence in Temeke district ranged from 8% to 36%, and Kinondoni 
from 21% to 38% while for schistosomiasis the range of infection across the region ranged from 10% 
to 15% in the sentinel sites. A review of schistosomiases by Mazigo et al. in 2012 also indicated a 
much higher prevalence compared to our findings [105]. There has been limited or no district wide 
MDA has been a challenge in the study areas though the national programme had been treating 
most of the coastal and inland districts. One round of school based MDA was done in 2005 in 
Mwanza by the National Schistosomiasis Control Programme (NSCCP) whereby school aged children 
were treated with praziquantel and albendazole in both Dar es Salaam and Mwanza districts. In the 
Dar es Salaam region (urban areas) community members aged 5 years and above received 2 rounds 
of MDA in year 2006 and 2007 using ivermectin and albendazole for LF elimination. Due to 
unavoidable reasons no more MDA rounds were conducted in the Dar and Mwanza since 2007. 
Baseline data collection for this study was done in 2013, prior to MDA conducted by the national 
programme. This was the district wide MDA with praziquantel and albendazole in all primary schools 
in Mwanza. In Dar es Salaam districtwide ivermectin and albendazole MDA was administered to all 
people above 5 years and praziquantel only to school aged children (5 to 17 years of age). Despite 
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many obstacles and interrupted MDA activities, the helminth prevalence found in year 2013, the 
baseline survey for my studies, were much lower, than generally expected. Impact data was 
collected 12-14 months after MDA and was in 2014. 
This study found no case of schistosomiases, 1 case of hookworm and no other STH in the urban 
areas. Positive cases for all helminth infections were only found in rural areas. T. trichiura and A. 
lumbricoides and hookworms are sensitive to treatment with albendazole, so the LF treatments in 
Dar es Salaam, using ivermectin and albendazole might have had an overlapping effect on the 
prevalence of STH. These findings were supported by Massa et al., who reported the combined 
effects of LF treatment on STH. [106]. In addition, emerging findings seem to be consistent with 
findings from a recent study conducted in Dar Es-Salaam and Tanga regions which also showed less 
than 1% STH and SCH prevalence [107]. Prevalence of LF was higher in urban than rural areas as 
reported in several other studies. The urban areas in this study were the coastal areas. Several 
studies have noted same dominance of disease in coastal areas compared to inlands [53, 108, 109]. 
5.5.3. Helminth infections and gender 
In the survey, male individuals were more prone to S. haematobium than females. Similar findings 
were observed in a study conducted a decade ago in Kinondoni district, Dar es Salaam region [110] 
and in Ethiopia [111]. But for the case of S. mansoni, results from the survey showed no gender 
difference among school aged children; a finding similar to a study conducted in Mwanza [112, 113]. 
The observed increased risk in males for schistosomiasis could be due to the social economic 
activities among males, for example, fishing activities. For LF, however, no gender difference was 
noted which correlates to recent findings in Dar es-salaam and Tanga regions [114, 115]. 
Nevertheless these findings are contrary to studies conducted in Tanzania, Congo and Nigeria which 
indicated male dominance in prevalence of LF infection, but only for individuals above 18 years of 
age [109, 116, 117].  
5.5.4. Helminth infections and age 
This study has indicated a significantly higher prevalence of S. haematobium among children aged 
11-17 years old than their younger counterparts. This may be attributed to the fact that the older 
group are more likely to play in water bodies and thereby be exposed to breeding sites for the 
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disease causing pathogens. For hookworm no significant trend was noted between younger and 
older children [91, 92].  
A notable trend in prevalence of LF increase with age was observed at baseline in 2013. This 
correlated with findings from a study done in Tanga which is also a coastal region like Dar es Salaam 
(both regions are in Tanzania) [61, 118]. However after 1 round of MDA the CFA prevalence of the 
infection seemed to decrease but remained high in participants aged 18-24 years old. These finding 
might be attributed to low MDA compliance especially for urban communities due to diverse 
activities and reluctance on MDA as a community based activity. This same low compliance for 
urban communities is noted in a study by Ramaiah et al., [119].  
5.5.5. Multiple helminth infections 
Studies in Mwanza and Pemba indicated existence of coexistence multiple helminth infections in 
one individual [73, 120]. Our findings also indicate that most co-infections were either hookworm 
and S. haematobium or hookworm and S. mansoni. However, in another study conducted earlier in 
Mwanza region, Lwambo et al. (1999), found that hookworm and S. mansoni co-infections occurred 
more frequently as multiple infections than as single species infection [76]. It was planned to 
investigate the role of polyparasitism on stunting, underweight and anaemia. However, only few 
individuals had more than one parasite, hence, this analysis could not be performed. 
5.5.6. Helminth & nutritional Status 
The study also evaluated the association between helminth infections and some important health 
indicators such as nutritional status (stunting, underweight), anaemia and allergies. 
Among the 3 helminth infections, stunting was significantly associated with only hookworm infection 
(crude and adjusted). Findings from Uganda indicated also the relationship of S. mansoni with 
stunting [121]. These findings are consistent with findings by Lwambo and Lwanga et al. [122-124]. 
Our study showed a non- significant 1.5 times increased risk of stunting in participants infected with 
S. mansoni. However, because of small numbers of infection in my study, this finding remained a 
trend, but remains concordant with the findings from Lwambo and Lwanga.  
Underweight was positively associated with the infection of both Schistosoma species and also 
hookworm in the crude analysis. However, after adjustment for age, gender and area, no significant 
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influence of helminth infections in underweight was seen anymore. This finding is supported by a 
study from Ethiopia indicating no association of STH and nutritional status [125].  
 
5.5.7. Anaemia general 
Prevalence of anaemia reported in this study in 2013 was 22.7% which is comparable to the Tanzania 
HIV& Malaria indicator Survey (THMIS) which reported a prevalence of 19% for Mwanza region in 
year 2012 [126]. However, the prevalence was low as compared to that recorded in other studies of 
school children in Tanzania. Studies done by Kinunghi and Lwambo showed prevalence of anaemia 
to be 34% and 62.6% respectively in the same region of Mwanza [122, 127] while Hall et al. reported 
a prevalence of 52% in Lake zone [128]. In Tanga Region, Tatala et.al. reported anaemia prevalence 
of 79.6% which was higher than the previous studies [129]. The relatively low anaemia observed in 
the present study may be attributed to the low helminths infection prevalence and intensities with 
less coinfections in the study communities. 
This study indicated that participants aged 11-17 years old were 1.5 times more at risk for anaemia 
compared to younger children. This observation is largely explained by the higher prevalence of 
anaemia among 11-17 years olds compared to 5-10years olds at baseline in 2013. However, these 
findings are interesting as they are in contrast with earlier studies which showed an inverse 
relationship between prevalence of anaemia with age among school age children as reported in 
Tanzania by Lwambo et al and by Mupfasoni et al., in Rwanda [122, 124]. The increase in anaemia 
with age may be explained by correlation of age with stunting, underweight and also malaria as we 
noted same trend in all mentioned aspects. 
5.5.7.1. Helminths and anaemia 
Prevalence of anaemia was significant associated with all helminth infections with the exception of 
S.mansoni, This association is also found in other studies conducted elsewhere [122, 130, 131]. 
Likewise the present study indicated that individuals with “any infection” were 1.7 times more at 
risk of being anaemic (adjusted). Another study in Uganda indicated that heavily S. mansoni and 
hookworm infected children had low haemoglobin levels and improved after praziquantel and 
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albendazole treatment [17]. Contrary ,a study in Rwanda reported neither association of helminth 
and anemia nor helminth with stunting [132]. 
 
5.5.7.2. Anaemia and malaria 
Evaluation of anaemia before and after helminth treatment was conducted in areas where malaria 
is also prevalent. There were more cases of malaria in year 2014 compared with 2013 and this largely 
explains the increase of anaemia in year 2014. This was unexpected and affected the investigation 
of the effects of helminth treatment on anaemia. In the rural areas prevalence of anaemia increased 
by 6 times in 2014 compared to 2013. This increase correlated to increase in malaria incidence 
prevalence in both Sengerema and Kwimba in 2014 compared to 2013 (THMIS unpublished data). 
Low coverage of malaria prevention interventions can result in increased malaria burden. In 2014, 
indoor residual spraying (IRS) was not done in both Kwimba and Sengerema districts unlike 2013 
when IRS was done in Sengerema. In addition, it can be expected that by 2014 community coverage 
with long lasting insecticidal nets (LLINs) may have decreased considerably following net attrition 
since the mass net distribution campaign in 2011. Malaria transmission is throughout the year but is 
increased during the rainy season. For Dar es Salaam (urban areas) surveys were collected almost 
during same seasons. Therefore, the effect is well compared while for rural areas (Mwanza) there 
was a difference between baseline (July) and impact time (September-October) and this might be 
associated with infection peak season. As a result, data collection timings could be a contributing 
factor for the difference in malaria prevalence observed especially in rural areas between years of 
surveys. 
The results from the two surveys indicated that after 1 round of MDA there was a crude reduction 
in anaemia by 47% in urban areas. Findings also noted less participants infected with malaria were 
from urban areas compared to rural areas. The results of low prevalence in the urban districts are 
supported by previous surveys in 2011 [126]. This might be explained by increased awareness on 
mosquito control and use of bed nets in urban areas. Similar findings of low urban malaria 
prevalence was noted in a study conducted in Tanga city in year 2007 [133]. 
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5.5.8. Helminths & allergy surrogate marker 
In the survey more skin prick positive individuals were found in rural areas than in urban areas. This 
is in contrast to previous findings by Cooper et al., [30], though newer publications have similar 
findings. For example, writing in 2006, Bloomfield questioned whether it would be time to abandon 
the hygiene hypothesis [134]. Webb et al., found helminths positively associated with atopy [135]. 
In the present  study, more helminth were found in rural areas and participants from rural areas 
(adjusted) were 4.8 and 4.5 times more at risk of being reactive for D. farinae and D. pteronyssinus 
allergens respectively than in participants from urban areas; a finding similar to studies by Webb and 
Bloomfield. Again, this is in contrast to other findings whereby helminth infections were reported to 
be inversely related to allergies [36, 136, 137]. Emerging findings showed that the relationship 
between helminth infections and allergies was only among participants infected with hookworms, 
who were reactive to D. farinae and D. pteronyssinus. After adjusting for effect of sex, age, areas and 
other infections (S. haematobium) the risk of being reactive to D. pteronyssinus allergen remained 
significant and was 5.8 times more among hookworm infected participants compared to those not 
infected. A recent published study reported similar findings on direct relationship between atopy 
and helminths infections in Uganda [135]. Whether this indicates that hookworm promoted allergic 
reactions specifically with dust mites, or whether a cross reactivity of IgE might explain this results, 
needs further evaluation. For sensitization against cockroach a different pattern was found in our 
study, cockroaches are less found in rural areas and more in urban areas, which might be explained 
by environmental factors favoring them. Again, a recent study by Nyan et al also reported that the 
risk of being sensitized to a cockroach allergens less by 60% in rural areas [36]. In summary, my study 
cannot support the hygiene hypothesis by D. Strachan but is in agreement with recent publications 
challenging the concept [34, 134]. Unfortunately, a planned post treatment evaluation of skin prick 
test positivity could not be performed because of technical problem. Therefore, potential changes 
in skin prick positivity after helminth treatment cannot be reported. 
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5.6. Helminths infection prevalence reduction (impact of MDA) 
In the year 2014, prevalence of all endemic helminths decreased. However, after adjusting for age, 
sex, anaemia and stunting, prevalence of S. haematobium infection decreased significantly by 74% 
and those who had single infections reduced significantly.  Among participants with double and triple 
infection prevalence was also reduced. Similar findings of helminths infection prevalence reduction 
after several rounds of MDA were reported in several studies conducted in the country [114, 118, 
124, 138]. Our findings also indicate a low S. mansoni prevalence and non-significant reduction after 
1 round of MDA. S. mansoni and Hookworm infections significantly dropped after several rounds of 
comprehensive interventions including MDA and PHAST implemented in Kome Island [139]. 
Reduction of prevalence of participants with “any infection was 63% (adjusted) after (1) one of MDA. 
Therefore our findings suggest that even a single round of MDA may have an impact on helminth 
infection. The intensity of helminth infections specifically S.mansoni significantly decreased in the 
2014 survey as compared to an earlier survey in 2013. There was neither heavy nor moderate 
infections categories of all the 3 helminths in year 2014. This trend in category reduction is also 
promoted and recommended by WHO. 
The reduction of infection intensity after interventions has been noted in several other studies. For 
instance a study in Zanzibar by Knopp et al in 2010 indicated that several rounds of MDA treatment 
decreased helminth intensity although prevalence and anaemia remain unchanged [140]. 
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6. CONCLUSION 
This study shows several interesting results: At baseline the three helminth infections, hookworm, 
S. mansoni and S. haematobium showed a significant association with underweight in children, while 
hookworm and S. haematobium were also associated with stunting and anaemia. Rural areas were 
more affected with helminth infections than urban areas. One round of mass drug administration 
with appropriate anthelminthic drugs showed a significant reduction in prevalence for S. 
haematobium and a marked significant reduction for S. mansoni and hookworm intensity was 
demonstrated too. There was a significant reduction of prevalence of participants with single 
helminth infection as well as those with “Any infection” .Interestingly, after one round of MDA, a 
non-significant reduction of the stunted and helminth infected children and increased prevalence of 
anaemia was observed mostly in rural areas. The increase in anaemia is explained by malaria 
increase in 2014. Malaria is an acute life-threatening infection has a much more dramatic influence 
on blood parameters than helminth infections. As the malaria prevalence rose between 2013 and 
2014 also supported by THMIS. An increase in anaemia was seen only in the rural areas of Mwanza. 
In contrast, in the coastal urban areas, a drop in anaemia was seen after helminth treatment, 
demonstrating the positive effect of the MDA activity. This demonstrates the challenge of cross 
sectional studies, which focus on a specific group of diseases. If information about additional 
diseases in the study area is not available, a change in prevalence of that other sickness can severely 
influence the outcome and lead to wrong interpretations. Despite solving this severe problem of 
potential confounding, this study had several additional limitations. For example, the overall 
prevalence of helminth infections in the chosen areas was much lower than expected, therefore, 
reducing the possible effects on outcome parameters and also effects of interventions. Another 
unfortunate limitation was the unavailability of the tests for allergic surrogate marker at baseline. 
As our results for 2014 were interesting and different to some of the previous reports, it would have 
added enormously to the interpretation to have results after helminth treatment. 
Mainly schistosomiases and hookworm infections are still prevalent in Tanzania and rural areas are 
still more affected. A positive association between helminth infection prevalence/intensity and its 
impact indicators such as stunting, underweight, anaemia was observed. Although only 1 round of 
anthelminthic medicines PCT was administered, it offers hope for effective intervention against 
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helminth prevalence and intensity. Other diseases, like malaria occur in similar areas, and have to 
be taken into account, when evaluating the effect of MDA activities. Therefore PCT intervention 
needs to be promoted to gain multiple effects on helminths infection reduction and its associated 
health impact indicators.  
6.1. Policy recommendations 
The survey has revealed that after one round of MDA there was a considerable reduction in the 
prevalence and intensity of infection with helminthiases although they still pose health problem. We 
recommend that NTDCP continues with regular mass treatment according to the WHO guidelines 
for their eventual elimination as evidence from other countries has shown. This should be done hand 
in hand with regular monitoring and evaluation to detect any visible changes in the status of infection 
and intensity. The monitoring should target not only the presence of parasites, but other health 
indicators associated with helminth infections as well. The monitoring should also aim to inform on 
research needs of the programme. 
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